Other and unspecified local infections of skin and subcutaneous tissue

L12_INFECT_SKIN_NAS

Tuberculosis, Cutaneous: Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L08 Hospital discharge: ICD-9 — 686 Hospital discharge: ICD-8 — 68698\|6869[0-1] Hospital discharge: excluded ICD-10 — L08.1 Hospital discharge: excluded ICD-9 — 6860 Cause of death: ICD-10 — L08 Cause of death: ICD-9 — 686 Cause of death: ICD-8 — 68698\|6869[0-1] Cause of death: excluded ICD-10 — L08.1 Cause of death: excluded ICD-9 — 6860 2 out of 7 registries used, show all original rules.	4174
4. Check minimum number of events None	4174
5. Include endpoints None	4174
6. Filter based on genotype QC (FinnGen only)	4018

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L00-L08
Name in latin: Aliae infectiones locales cutis et telae subcutaneae

NAME	L12_INFECT_SKIN_NAS
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L08
HD_ICD_9	686
HD_ICD_8	68698\|6869[0-1]
HD_ICD_10_EXCL	L08[1-2]
HD_ICD_9_EXCL	6860
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L08
COD_ICD_9	686
COD_ICD_8	68698\|6869[0-1]
COD_ICD_10_EXCL	L08[1-2]
COD_ICD_9_EXCL	6860
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified local infections of skin and subcutaneous tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4018	2070	1948
Unadjusted period prevalence (%)	0.81	0.73	0.89
Median age at first event (years)	56.00	53.15	59.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4174: Matched controls
41740

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.9

315.6

411

504

L08.0

ICD-10 Finland

Pyoderma

74.0

307.7

542

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

91.6

307.7

1894

375

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

89.9

307.7

1806

351

A46

ICD-10 Finland

Erysipelas

4.8

307.7

1152

3081

J01FF01

ATC

clindamycin; systemic

3.3

295.0

1649

6824

S97

ICPC

Chronic ulcer skin

6.1

283.9

536

984

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

10.8

277.6

310

309

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.7

275.5

469

776

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

11.0

248.7

273

265

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.7

228.1

860

2724

J01DB01

ATC

cefalexin; oral

4.9

204.5

3831

28941

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

9.6

191.5

230

252

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

8.1

190.5

264

346

J01CF05

ATC

flucloxacillin; systemic

4.7

184.0

466

1095

NHQ40

NOMESCO Finland

Amputation of toe

11.9

180.1

185

162

L03.9

ICD-10 Finland

Cellulitis, unspecified

11.6

174.5

182

163

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

167.2

680

2233

C03CA01

ATC

furosemide; systemic

2.4

147.6

1422

7316

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.2

141.0

656

2324

E0000UV, ,

ATC

2.2

135.2

1985

12093

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.3

134.2

575

1936

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.8

133.5

770

3070

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.5

132.4

1060

4974

S18

ICPC

Laceration/cut

2.2

126.3

2088

13217

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.0

124.2

644

2417

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

121.6

2088

13347

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

120.3

1109

5515

J01MA12

ATC

levofloxacin; systemic

2.5

117.1

940

4387

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.2

116.4

507

1717

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.7

116.3

225

416

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

11.6

115.0

119

105

N02AX02

ATC

tramadol; systemic, rectal

2.1

112.4

1938

12291

J01MA02

ATC

ciprofloxacin; systemic

2.1

109.3

1771

10946

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

13.6

107.6

101

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.4

106.7

407

1268

L89

ICD-10 Finland

Decubitus ulcer and pressure area

7.1

106.0

163

239

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.9

103.9

325

886

A10AB05

ATC

insulin aspart; parenteral

3.2

102.2

453

1546

A10AE04

ATC

insulin glargine; parenteral

2.9

101.8

533

1999

TQW80

NOMESCO Finland

Local dermatologic skincare

5.3

100.3

209

413

D07AC01

ATC

betamethasone; topical

2.0

99.5

1636

10078

R60.0

ICD-10 Finland

Localized oedema

2.7

98.9

617

2535

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.6

98.9

161

251

S76

ICPC

Skin infection other

3.7

97.6

327

934

N02AA05

ATC

oxycodone; systemic

2.3

95.8

841

4048

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

4.5

94.9

241

562

H02AB06

ATC

prednisolone; systemic

1.9

93.5

2085

14172

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.9

93.0

171

301

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

91.4

691

3105

L03.0

ICD-10 Finland

Cellulitis of finger and toe

3.0

91.4

432

1527

QDA10

NOMESCO Finland

Incision of skin of lower limb

14.7

91.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

91.0

373

1212

N03AX16

ATC

[U] pregabalin

2.1

90.0

1068

5795

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.6

89.1

174

324

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

88.4

656

2920

68698

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Aliae definitae

+∞

86.8

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.6

85.8

548

2269

J01DA01

ATC

[U] cefalexin

1.9

84.8

2620

19560

R50.9

ICD-10 Finland

Fever, unspecified

2.3

84.4

760

3680

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

84.1

795

3927

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

83.5

1127

6390

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.8

83.4

154

272

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

83.1

911

4775

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

17.9

82.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

82.7

509

2067

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

82.5

435

1630

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

48.5

82.3

A10AC01

ATC

insulin (human); parenteral

2.9

82.2

411

1496

ZZA00

NOMESCO Finland

Split skin graft

4.8

81.3

187

402

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

5.2

80.3

167

329

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

79.6

782

3916

127

Kela drug reimbursment

Transplant complication

6.3

78.4

133

216

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

77.7

624

2867

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

77.2

1157

6777

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

76.6

1070

6113

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

76.1

1333

8222

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.2

75.8

158

312

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

75.5

598

2729

L17

ICPC

Foot/toe symptom/complaint

1.9

75.0

1254

7609

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

74.8

1294

7939

L04AA06

ATC

mycophenolic acid; systemic

5.6

74.0

144

267

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

73.9

1340

8342

E000001, ,

ATC

2.1

73.3

925

5084

L30.3

ICD-10 Finland

Infective dermatitis

4.0

73.3

219

576

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

6.9

72.9

113

167

H3603, E103,

ICD-10 Finland

9.1

72.4

100

QBA10

NOMESCO Finland

Incision of skin of trunk

10.4

72.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

70.1

329

1153

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

5.6

69.9

134

245

D07AB08

ATC

desonide; topical

2.4

69.5

535

2405

Z3231

NOMESCO Finland

Registered nurse

1.9

69.4

1208

7393

SPAT1255

SPAT

Intravenous administration of medicine

2.9

69.3

359

1329

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.9

68.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

68.7

1235

7632

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.3

68.7

Z94.0

ICD-10 Finland

Kidney transplant status

7.1

67.8

103

149

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

67.7

354

1317

ZXD05

NOMESCO Finland

Urgent procedure

1.8

67.6

1315

8324

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.4

67.4

112

178

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.9

67.2

118

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.5

66.5

130

242

TK800

NOMESCO Finland

Hemodialysis

4.9

65.8

147

308

ZX120

NOMESCO Finland

Intravenous

2.5

65.3

459

1978

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

65.2

839

4622

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

7.0

64.4

142

A10AB01

ATC

insulin (human); parenteral

3.7

64.2

210

588

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

64.2

731

3850

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.4

63.7

242

747

N03AX12

ATC

[U] gabapentin; oral

2.1

63.3

728

3846

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.2

63.1

171

418

N02BE01

ATC

paracetamol; systemic, rectal

2.2

62.9

3665

31873

M79.6

ICD-10 Finland

Pain in limb

1.7

62.6

1714

11931

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

62.3

1532

10341

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.7

62.3

205

576

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

62.1

304

1090

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

61.9

1122

6915

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.8

61.7

140

297

S29

ICPC

Skin symptom/complaint other

2.0

61.7

838

4695

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.8

61.7

113

198

NGQ20

NOMESCO Finland

Amputation of lower leg

12.7

61.5

SPAT1262

SPAT

Handing over of treatment supplies

2.0

61.5

764

4148

L73.2

ICD-10 Finland

Hidradenitis suppurativa

8.1

61.0

103

WX213

NOMESCO Finland

Lower leg blockade

8.9

60.9

D09AB01

ATC

zinc bandage without supplements; topical

4.9

60.4

134

279

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.9

60.0

105

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

13.9

59.6

R06.0

ICD-10 Finland

Dyspnoea

1.8

59.5

1118

6954

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

59.4

520

2463

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.5

59.3

115

P01AB01

ATC

metronidazole; oral, rectal

1.7

58.4

1595

11038

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

58.3

803

4512

L04AD01

ATC

ciclosporin; systemic

4.8

58.2

132

280

ZXA00

NOMESCO Finland

Right side

1.8

57.7

1084

6731

B01AB05

ATC

enoxaparin; parenteral

1.8

57.6

1265

8227

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

57.5

823

4683

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

57.4

970

5827

D07AD01

ATC

clobetasol; topical

2.0

57.1

714

3877

A10AE05

ATC

insulin detemir; parenteral

2.9

57.0

280

1005

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

5.1

57.0

120

239

A02BC02

ATC

pantoprazole; systemic

1.7

56.8

2726

21851

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

56.8

698

3766

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.8

56.6

180

494

D07AC13

ATC

mometasone; topical

1.8

56.3

1203

7751

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

55.7

451

2064

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

55.6

577

2921

D06AX01

ATC

fusidic acid; topical

2.3

55.5

442

2008

6869X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Unspecified local infection of skin and subcutaneous tissue

+∞

55.3

Z2446

NOMESCO Finland

Social worker

2.6

55.3

338

1359

R06AE07

ATC

cetirizine; oral

1.7

55.2

1796

12967

L28

ICPC

Limited function/disability (L)

2.0

55.0

734

4072

A12AA04

ATC

calcium carbonate; oral

5.3

54.7

111

214

V03AE01

ATC

polystyrene sulfonate; oral

6.0

54.6

165

P19

ICPC

Drug abuse

8.4

54.4

L04AA01

ATC

[U] ciclosporin

5.9

54.4

169

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.1

54.2

118

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

54.2

333

1342

S10

ICPC

Boil/carbuncle

2.9

54.1

266

955

SPAT1151

SPAT

Treatment of major wounds

6.6

53.6

135

D07AA02

ATC

hydrocortisone; topical

2.0

53.4

634

3373

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

53.2

389

1701

AA1AD

NOMESCO Finland

CT of head and brain

1.8

53.1

1096

6970

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.7

53.1

130

M86.6

ICD-10 Finland

Other chronic osteomyelitis

16.2

53.0

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.8

52.7

R4110

NOMESCO Finland

Physiotherapy

1.8

52.5

1145

7395

WX002

NOMESCO Finland

Sedation and analgesia

1.9

52.4

803

4658

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

52.2

463

2200

L04AD02

ATC

tacrolimus; systemic

6.4

52.1

139

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.2

52.1

108

L30.4

ICD-10 Finland

Erythema intertrigo

5.6

52.0

180

T89

ICPC

Diabetes insulin dependent

3.2

51.9

219

720

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

51.7

2149

16415

R11

ICD-10 Finland

Nausea and vomiting

2.3

51.7

408

1845

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

51.5

224

750

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

51.5

558

2868

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

51.3

315

1268

137

Kela drug reimbursment

Uraemia requiring dialysis

6.9

51.3

116

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

50.7

1715

12427

A10AB04

ATC

insulin lispro; parenteral

3.6

50.6

175

508

H02AB04

ATC

methylprednisolone; systemic

2.0

50.4

616

3306

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

50.0

636

3462

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

18.3

49.9

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

49.7

504

2524

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

20.2

49.5

A28

ICPC

Limited function/disability NOS

1.9

49.5

680

3799

A10AA01, ,

ATC

3.9

49.3

150

399

N05AH04

ATC

quetiapine; oral

1.9

49.2

749

4327

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

49.2

184

562

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

49.2

418

1949

ZXA05

NOMESCO Finland

Left side

1.8

49.1

981

6159

J01DA09

ATC

[U] cefadroxil

1.7

49.0

1087

7032

A11CC03

ATC

alfacalcidol; systemic

4.0

48.8

142

366

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

48.7

788

4641

UJF32

NOMESCO Finland

Coloscopy

1.7

48.5

1033

6604

SPAT1254

SPAT

Administration of medicine

2.0

48.4

647

3578

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.4

48.1

180

550

L04AX01

ATC

azathioprine; systemic

3.0

48.0

223

775

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

47.7

1779

13143

A10AA02, ,

ATC

3.4

47.7

173

518

SPAT1263

SPAT

Sampling

1.6

47.7

1685

12286

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

47.3

178

546

A06AD11

ATC

lactulose; oral

2.0

47.2

603

3282

Z3226

NOMESCO Finland

Physiotherapist

1.9

46.9

768

4534

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.1

46.9

134

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

46.6

415

1972

L03.3

ICD-10 Finland

Cellulitis of trunk

9.9

46.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.9

46.1

230

831

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

46.1

390

1813

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

45.6

1682

12353

L20.0

ICD-10 Finland

Besnier prurigo

2.3

45.5

353

1581

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.8

45.4

142

385

S21

ICPC

Skin texture symptom/complaint

2.0

45.4

599

3294

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

5.2

45.3

181

V03AE02

ATC

sevelamer; oral

9.6

45.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

45.0

656

3728

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

4.9

44.7

202

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.3

44.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

44.0

1402

9918

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

44.0

232

864

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

43.9

550

2969

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

43.9

1464

10471

L73.8

ICD-10 Finland

Other specified follicular disorders

6.2

43.8

123

N18.0

ICD-10 Finland

End-stage renal disease

6.2

43.8

123

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.6

43.8

149

428

D07BC01

ATC

betamethasone and antiseptics; topical

2.0

43.7

515

2719

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

43.7

393

1873

N18.8

ICD-10 Finland

Other chronic renal failure

3.8

43.5

133

355

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

15.3

43.4

R53

ICD-10 Finland

Malaise and fatigue

1.7

43.0

966

6236

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

42.8

305

1315

M04AA01

ATC

allopurinol; systemic

2.0

42.6

533

2873

X58

ICD-10 Finland

Exposure to other specified factors

1.9

42.5

603

3392

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.5

42.4

B05DA

ATC

Isotonic solutions

6.8

42.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

42.4

402

1956

J01AA07

ATC

tetracycline; systemic

1.9

42.3

617

3502

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.8

42.3

SPAT1301

SPAT

No procedures

1.6

42.1

1234

8530

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

42.1

402

1961

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

41.7

438

2215

C03DA01

ATC

spironolactone; oral

2.0

41.7

484

2541

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

41.5

993

6512

N05BA04

ATC

oxazepam; oral

1.7

41.5

1018

6721

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.0

41.3

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

5.5

41.2

148

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

40.6

210

774

R4180

NOMESCO Finland

Podiatric therapy

5.3

40.5

154

S19

ICPC

Skin injury other

2.9

40.5

199

713

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

40.5

910

5863

T90

ICPC

Diabetes non-insulin dependent

1.7

40.1

903

5821

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.3

39.9

104

247

J02AC01

ATC

fluconazole; systemic

1.6

39.9

1449

10517

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

39.8

720

4361

B05DB

ATC

Hypertonic solutions

7.1

39.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

39.7

1177

8137

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.8

39.5

120

319

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

39.4

2854

24112

SPAT1211

SPAT

Application of soft bandage

2.1

39.3

379

1855

N05CF01

ATC

zopiclone; oral

1.6

39.2

1225

8573

J01CF02

ATC

cloxacillin; systemic

3.8

39.0

120

322

B03XA02

ATC

darbepoetin alfa; parenteral

3.9

39.0

118

313

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

38.9

190

679

J01MA14

ATC

moxifloxacin; systemic

2.1

38.7

383

1892

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

38.7

522

2882

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.9

38.6

M10.9

ICD-10 Finland

Gout, unspecified

2.3

38.4

300

1346

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.4

38.4

E000002, ,

ATC

2.0

38.1

465

2480

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

38.1

409

2084

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

7.8

37.9

N05BA01

ATC

diazepam; systemic, rectal

1.9

37.8

523

2911

SPAT1229

SPAT

Assessment of need for aid

2.2

37.7

321

1493

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

37.7

297

1337

E000003, ,

ATC

2.7

37.7

209

798

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

37.6

552

3131

N06AX11

ATC

mirtazapine; oral

1.6

37.6

1303

9325

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

37.4

1190

8348

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.9

37.3

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.1

37.3

156

510

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.0

37.1

R51.80

ICD-10 Finland

Headache

1.8

37.0

642

3833

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

36.9

236

967

A10BA02

ATC

metformin; oral

1.6

36.8

1058

7238

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

36.7

524

2944

E000006, ,

ATC

2.3

36.6

286

1283

JN4AD

NOMESCO Finland

Body CT examination

2.0

36.4

402

2068

N30.0

ICD-10 Finland

Acute cystitis

1.8

36.3

615

3646

J01XC01

ATC

fusidic acid; systemic

4.9

36.3

166

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

36.1

146

468

WX892

NOMESCO Finland

Monitored bed care

2.2

36.0

333

1601

Z2221

NOMESCO Finland

Medical doctor

1.6

35.9

1070

7374

ZXE00

NOMESCO Finland

One hour or less

1.5

35.9

1497

11137

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

35.9

236

979

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.8

35.8

168

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

35.7

345

1688

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

35.7

586

3440

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

35.6

190

711

I50.0

ICD-10 Finland

Congestive heart failure

2.3

35.6

289

1317

XQ802

NOMESCO Finland

Epicutan test

2.8

35.4

184

679

D02AE01

ATC

carbamide; topical

2.3

35.4

280

1262

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

35.3

275

1231

WX402

NOMESCO Finland

General anaesthesia

1.7

35.3

844

5502

C07AB07

ATC

bisoprolol; oral

1.5

35.3

1798

13943

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

35.2

890

5886

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.1

35.2

236

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.8

35.2

109

294

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

35.1

207

815

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

10.4

35.1

J01FA06

ATC

roxithromycin; oral

1.5

35.0

1518

11374

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.6

34.8

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.7

34.8

172

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

34.6

383

1970

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.9

34.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

34.5

1449

10774

N06AX21

ATC

duloxetine; oral

1.9

34.4

468

2587

XQ848

NOMESCO Finland

Dermatological photography

3.1

34.3

146

482

ZY010

NOMESCO Finland

Hospital outpatient

2.4

34.3

237

1007

N06AB04

ATC

citalopram; systemic

1.7

34.1

795

5144

R52.9

ICD-10 Finland

Pain, unspecified

2.0

34.0

397

2082

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

7.8

34.0

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.6

34.0

113

320

E66.8

ICD-10 Finland

Other obesity

2.4

33.7

233

990

N02BF02

ATC

pregabalin; oral

2.4

33.6

252

1110

205

Kela drug reimbursment

Chronic hypertension

1.6

33.6

965

6578

A01

ICPC

Pain general/multiple sites

2.0

33.5

371

1908

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

33.5

355

1797

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

4.5

33.4

182

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.4

33.3

122

368

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

33.3

138

449

H3601, E103,

ICD-10 Finland

6.0

33.2

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

33.2

1067

7463

W19

ICD-10 Finland

Unspecified fall

2.0

33.2

401

2128

J04AB02

ATC

rifampicin; systemic

4.8

33.2

159

D07XC01

ATC

betamethasone; topical

1.9

33.1

484

2736

SPAT1260

SPAT

Consultation of another employee

1.7

33.1

686

4299

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

32.9

199

793

H04AA01

ATC

glucagon; nasal, parenteral

3.3

32.9

123

376

Z71.8

ICD-10 Finland

Other specified counselling

1.5

32.8

1185

8509

N03AX09

ATC

lamotrigine; oral

2.5

32.7

213

880

WZC30

NOMESCO Finland

Teaching

1.7

32.5

620

3795

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

32.5

320

1576

Z49.2

ICD-10 Finland

Other dialysis

6.0

32.4

M54.5

ICD-10 Finland

Low back pain

1.5

32.3

1354

10034

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.1

32.2

217

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

32.1

113

332

SPAT1153

SPAT

Removal of sutures

1.5

32.0

1181

8508

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

32.0

354

1820

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

11.0

32.0

Z72.2

ICD-10 Finland

Drug use

8.0

32.0

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

31.8

104

291

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

31.8

262

1201

J01AA02

ATC

doxycycline; systemic

1.5

31.6

2991

26034

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.6

31.6

109

L12

ICPC

Hand/finger symptom/complaint

1.7

31.5

636

3952

QCA10

NOMESCO Finland

Incision of skin of upper limb

12.5

31.5

L03

ICD-10 Finland

Cellulitis

5.3

31.5

120

UKC02

NOMESCO Finland

Cystoscopy

1.7

31.5

613

3772

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

31.4

404

2189

R03AC02

ATC

salbutamol; inhalant

1.5

31.3

2119

17242

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

31.1

463

2631

H02AB07

ATC

prednisone; oral

1.8

31.0

522

3079

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.2

31.0

125

400

B01AA03

ATC

warfarin; systemic

1.7

30.8

701

4497

J01AA04

ATC

lymecycline; systemic

1.8

30.7

520

3073

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

30.5

251

1150

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.5

30.5

190

769

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.7

30.4

164

617

N05CD07

ATC

temazepam; oral

1.9

30.4

434

2433

WVA20

NOMESCO Finland

Medicine administration

3.1

30.3

128

421

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

30.3

341

1763

S06.0

ICD-10 Finland

Concussion

1.9

30.3

432

2420

S20

ICPC

Corn/callosity

3.5

30.3

104

301

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

8.7

30.1

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.6

30.1

178

702

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

30.1

538

3229

X57

ICD-10 Finland

Unspecified privation

3.3

30.0

114

352

L60.0

ICD-10 Finland

Ingrowing nail

2.4

29.9

204

861

SPAT1312

SPAT

General health counselling

1.5

29.8

1219

8952

J01EA01

ATC

trimethoprim; systemic

1.6

29.8

933

6465

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.0

29.7

221

SPAT1216

SPAT

Assessment of functional ability

1.7

29.4

570

3499

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

29.3

666

4267

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

29.3

272

1309

A07AA02

ATC

nystatin; oral

2.3

29.2

233

1053

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.6

29.1

280

WX320

NOMESCO Finland

Spinalanesthesy

1.6

29.0

889

6126

N02BF01

ATC

gabapentin; oral

2.0

28.9

321

1652

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

28.8

245

1137

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

28.8

116

371

N05BB01

ATC

hydroxyzine; systemic

2.2

28.7

259

1231

ZXA10

NOMESCO Finland

Bilateral

1.6

28.7

691

4491

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

28.7

801

5398

QDB10, ,

SPAT

3.9

28.7

218

L84

ICD-10 Finland

Corns and callosities

2.7

28.5

152

569

A02BC05

ATC

esomeprazole; systemic

1.5

28.3

1498

11555

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

28.3

289

1441

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.7

28.2

157

601

6868X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Other specified local infections of skin and subcutaneous tissue[ALIAE INFECTIONES LOCALES CUTIS ET SUBCUTIS]

+∞

28.2

S06

ICPC

Rash localized

2.3

28.1

231

1057

N05AH03

ATC

olanzapine; systemic

2.1

28.0

261

1257

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

28.0

2170

17956

A10AE06

ATC

insulin degludec; parenteral

2.7

28.0

150

563

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.2

28.0

178

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.9

28.0

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

28.0

117

383

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

27.9

124

420

C08CA01

ATC

amlodipine; oral

1.5

27.9

1359

10310

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

27.8

241

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

27.8

685

4474

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.8

27.8

A41.8

ICD-10 Finland

Other specified sepsis

3.6

27.6

252

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

25.5

27.4

F10.24

ICD-10 Finland

Alcohol depence active use

3.9

27.4

207

N06AX16

ATC

venlafaxine; oral

1.7

27.3

539

3322

N03AE01

ATC

clonazepam; systemic

2.2

27.2

233

1085

A02BC01

ATC

omeprazole; systemic

1.5

27.1

998

7144

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

5.8

26.8

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.5

26.7

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

26.7

294

1507

N05AX12

ATC

aripiprazole; systemic

2.5

26.7

173

713

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

26.7

167

677

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

26.7

740

4969

S01

ICPC

Pain/tenderness of skin

2.4

26.6

193

837

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

26.6

175

726

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

26.6

148

566

T82

ICPC

Obesity

2.6

26.6

163

654

H3600, E103,

ICD-10 Finland

4.5

26.6

143

T74.1

ICD-10 Finland

Physical abuse

3.6

26.6

244

G47.3

ICD-10 Finland

Sleep apnoea

1.6

26.6

848

5881

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

26.6

188

807

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

10.1

26.5

N06AB03

ATC

fluoxetine; oral

1.8

26.3

462

2753

NH3BG

NOMESCO Finland

MRI of foot

7.0

26.3

NH1AD

NOMESCO Finland

Ankle and foot CT

3.2

26.2

105

335

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

26.1

266

XQ902

NOMESCO Finland

Other photography

6.0

26.0

L03.2

ICD-10 Finland

Cellulitis of face

8.0

26.0

E87.5

ICD-10 Finland

Hyperkalaemia

3.6

26.0

243

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.8

25.9

122

L04AX03

ATC

methotrexate; systemic

1.9

25.9

376

2115

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

25.7

468

2817

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.1

25.7

109

360

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.8

25.7

130

474

QXB99, ,

SPAT

3.2

25.6

101

319

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

25.6

1035

7541

X84

ICD-10 Finland

Intentional self-harm by unspecified means

10.1

25.6

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

10.1

25.6

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

25.5

271

1371

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.4

25.5

148

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.1

25.4

107

352

M25.5

ICD-10 Finland

Pain in joint

1.5

25.3

1165

8705

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

9.4

25.3

D02AX

ATC

Other emollients and protectives

2.6

25.3

144

558

RS220, ,

NOMESCO Finland

4.0

25.2

179

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

25.2

1323

10136

A10BH05

ATC

linagliptin; oral

2.3

25.1

198

891

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

25.1

1770

14299

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.4

25.0

146

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

25.0

269

1367

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

24.8

483

2960

N05AA02

ATC

levomepromazine; systemic

2.5

24.8

164

683

N03AG01

ATC

valproic acid; systemic, rectal

2.1

24.7

239

1167

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

9.1

24.7

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

24.7

213

995

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

7.8

24.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

24.7

273

1402

H3603, E113,

ICD-10 Finland

5.3

24.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

24.6

261

1320

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

24.5

270

1384

WX882

NOMESCO Finland

High dependency care

2.7

24.5

137

526

C09AA02

ATC

enalapril; systemic

1.6

24.4

678

4545

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

24.4

2073

17258

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.4

24.4

268

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

24.3

644

4271

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.5

24.3

133

TPX15

NOMESCO Finland

Removal of vascular injection port

6.6

24.3

XQ800

NOMESCO Finland

Prick test

2.0

24.2

291

1538

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

24.2

281

1468

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.7

24.1

208

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.2

24.1

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.4

24.1

138

WX704

NOMESCO Finland

Intubation

1.9

24.0

311

1685

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

24.0

196

895

D05BB02

ATC

acitretin; oral

3.0

23.9

106

359

WX214

NOMESCO Finland

Plexus blockade at the ankle

6.4

23.9

ZXD35

NOMESCO Finland

Usual procedure

2.6

23.8

136

528

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

23.8

1836

15018

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

7.0

23.7

R02

ICPC

Shortness of breath/dyspnoea

1.7

23.7

473

2918

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.5

23.7

239

NFQ20

NOMESCO Finland

Amputation of femur

5.8

23.6

L30.0

ICD-10 Finland

Nummular dermatitis

2.4

23.5

163

693

B01AB10

ATC

tinzaparin; parenteral

1.8

23.5

371

2139

L03.8

ICD-10 Finland

Cellulitis of other sites

8.2

23.5

NF3AA

NOMESCO Finland

Femur X-ray examination

3.2

23.5

300

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

23.4

225

1096

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.4

23.4

137

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

23.4

834

5906

XQ855

NOMESCO Finland

Skin temperature measurement

7.6

23.3

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.3

23.3

276

JN4BD

NOMESCO Finland

Extensive body CT

1.8

23.3

378

2198

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

23.3

243

1221

K07

ICPC

Swollen ankles/oedema

2.3

23.2

174

767

E000007, ,

ATC

2.2

23.1

211

1008

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.8

23.1

182

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.5

23.0

229

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.9

23.0

178

K08.3

ICD-10 Finland

Retained dental root

1.9

23.0

283

1508

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.3

23.0

185

840

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.9

22.9

174

A10AD01

ATC

insulin (human); parenteral

3.4

22.8

240

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

22.8

321

1787

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

22.8

221

R4190

NOMESCO Finland

Nutritional therapy

2.4

22.8

165

716

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

22.8

222

1088

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

22.7

152

636

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

22.6

276

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

22.6

284

1523

N06AA09

ATC

amitriptyline; systemic

1.8

22.6

343

1955

EBA00

NOMESCO Finland

Extraction of tooth

1.4

22.5

1338

10434

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.9

22.5

104

361

RD210, ,

NOMESCO Finland

3.1

22.5

308

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

22.5

2614

22792

J04BA02

ATC

dapsone; oral

6.0

22.5

A08

ICPC

Swelling

2.2

22.4

192

894

A10BB12

ATC

glimepiride; oral

2.0

22.4

242

1232

R42

ICD-10 Finland

Dizziness and giddiness

1.5

22.4

802

5679

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

22.4

1012

7508

A04

ICPC

Weakness/tiredness general

1.6

22.3

547

3554

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.7

22.3

191

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

22.3

728

5054

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.3

22.3

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

22.2

160

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

22.2

210

1018

J05AB01

ATC

aciclovir; systemic

1.5

22.1

782

5519

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

22.1

218

1073

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.4

22.0

241

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

21.9

153

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

21.8

193

911

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

21.8

339

1946

B01AC04

ATC

clopidogrel; oral

1.6

21.8

565

3721

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

21.7

864

6245

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.2

21.7

141

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

21.7

887

6447

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.5

21.5

WW200

NOMESCO Finland

Immunization

2.7

21.4

117

444

Z00.0

ICD-10 Finland

General medical examination

1.5

21.4

709

4932

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

21.4

391

2351

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

21.4

1014

7578

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

21.4

462

2907

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

21.4

172

781

K02.1

ICD-10 Finland

Caries of dentine

1.4

21.4

2233

19060

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

21.3

403

2446

C08CA13

ATC

lercanidipine; oral

1.6

21.3

497

3188

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

21.3

261

RJ420, ,

NOMESCO Finland

6.8

21.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

21.2

183

855

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.8

21.1

175

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

21.1

367

2176

WX290

NOMESCO Finland

Other blockage of nerve

1.4

21.1

1743

14321

R06AX22

ATC

ebastine; oral

1.6

21.1

612

4134

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.5

21.0

SPAT1310

SPAT

Counselling related to known health issue

1.4

20.9

1158

8897

D11AH01

ATC

tacrolimus; topical

4.3

20.9

128

S71.1

ICD-10 Finland

Open wound of thigh

4.3

20.8

124

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

17.9

20.8

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.0

20.7

243

1273

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

20.7

204

1004

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

20.7

232

1197

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.1

20.6

287

R33

ICD-10 Finland

Retention of urine

1.8

20.6

294

1643

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

20.6

483

3101

WW500

NOMESCO Finland

Blood transfusion

2.3

20.5

158

704

J01CA04

ATC

amoxicillin; systemic

1.4

20.5

3204

29106

C08CA05

ATC

nifedipine; systemic

2.0

20.4

223

1140

R03AC13

ATC

formoterol; inhalant

2.1

20.4

188

902

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

20.4

233

1210

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.4

20.3

223

N07BB01

ATC

disulfiram; oral

2.2

20.2

168

774

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

8.4

20.1

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

20.1

366

2198

S04

ICPC

Lump/swelling localized

1.7

20.1

376

2275

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.5

20.1

107

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

20.1

358

2138

B01AB04

ATC

dalteparin; parenteral

2.1

20.0

193

942

3AC01, ,

NOMESCO Finland

4.2

20.0

128

S09

ICPC

Infected finger/toe

2.4

20.0

132

550

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

19.9

2740

24293

P80

ICPC

Personality disorder

6.3

19.7

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

19.6

228

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

19.6

161

737

S11

ICPC

Skin infection post-traumatic

3.8

19.6

161

C02AC05

ATC

moxonidine; oral

2.1

19.6

178

849

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

19.6

223

1157

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

17.8

19.5

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

19.5

332

1957

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

19.4

942

7051

L01BA01

ATC

methotrexate; systemic

2.3

19.4

142

619

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

19.4

222

1154

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

19.4

800

5811

L14

ICPC

Leg/thigh symptom/complaint

1.8

19.3

282

1587

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

19.3

109

421

D05AX52

ATC

calcipotriol, combinations; topical

2.0

19.3

204

1030

A04AA01

ATC

ondansetron; systemic, rectal

1.8

19.2

280

1574

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.3

19.2

115

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

19.2

740

5301

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

19.2

252

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.9

19.1

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

19.1

289

D11

ICPC

Diarrhoea

1.6

19.1

426

2700

R03DC03

ATC

montelukast; oral

1.5

19.0

592

4055

D01AC02

ATC

miconazole; topical

1.8

19.0

279

1572

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

19.0

202

1022

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

19.0

127

532

L28.1

ICD-10 Finland

Prurigo nodularis

4.8

18.9

S22

ICPC

Nail symptom/complaint

1.9

18.9

234

1249

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.8

18.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

18.8

808

5909

H3600, E113,

ICD-10 Finland

3.9

18.8

143

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

18.8

720

5149

R5110, ,

SPAT

1.9

18.8

230

1223

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

15.9

18.8

A10BH01

ATC

sitagliptin; oral

1.7

18.8

328

1947

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

18.8

171

817

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

18.7

190

M10.0

ICD-10 Finland

Idiopathic gout

2.3

18.7

138

604

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.3

18.7

109

V03AE03

ATC

lanthanum carbonate; oral

6.8

18.7

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

18.7

158

733

SPAT1172

SPAT

Guidance concerning hydration

2.9

18.7

304

R03BB04

ATC

tiotropium bromide; inhalant

1.7

18.7

349

2111

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.9

18.6

294

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

18.6

226

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.4

18.5

126

532

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.0

18.5

284

C07AB02

ATC

metoprolol; systemic

1.5

18.5

668

4721

R4120

NOMESCO Finland

Occupational therapy

1.9

18.5

243

1323

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

18.5

247

1352

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

18.5

102

390

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

18.4

125

527

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

18.4

252

1389

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.2

18.4

L03

ICPC

Low back symptom/complaint

1.4

18.4

977

7425

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

18.4

193

973

SFA10

NOMESCO Finland

One-surface restoration

1.3

18.3

2030

17315

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.3

18.2

107

Z29

ICPC

Social problem NOS

2.8

18.2

330

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

18.2

471

3092

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

6.0

18.2

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.1

18.2

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.7

18.2

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.2

18.1

219

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

18.1

313

1851

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.7

18.1

371

J01XX08

ATC

linezolid; systemic

5.0

18.1

Y96.9

ICD-10 Finland

Unspecified type of accident

3.0

18.1

277

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

18.0

243

1333

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.3

18.0

108

P15

ICPC

Chronic alcohol abuse

2.4

18.0

121

508

M48.0

ICD-10 Finland

Spinal stenosis

1.6

18.0

407

2587

M86.1

ICD-10 Finland

Other acute osteomyelitis

15.4

17.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

17.9

206

1072

P99

ICPC

Psychological disorders other

2.4

17.9

119

498

A03

ICPC

Fever

1.5

17.8

614

4294

B35.3

ICD-10 Finland

Tinea pedis

2.1

17.8

172

840

A10AD05

ATC

insulin aspart; parenteral

3.1

17.8

237

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.0

17.8

RJ411, ,

NOMESCO Finland

5.3

17.8

J46

ICD-10 Finland

Status asthmaticus

2.5

17.8

109

439

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

17.8

163

781

A02BC03

ATC

lansoprazole; oral

1.4

17.8

985

7534

M86.8

ICD-10 Finland

Other osteomyelitis

18.1

17.8

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.5

17.7

168

N05CF02

ATC

zolpidem; oral

1.5

17.7

602

4199

PE1AT

NOMESCO Finland

Femoral artery PTA

3.8

17.7

145

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

17.6

201

1044

SPAT1240

SPAT

Therapeutic discussion

1.6

17.6

383

2411

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

17.6

1409

11432

B07.9

ICD-10 Finland

Verruca simplex

2.2

17.5

142

647

E86

ICD-10 Finland

Volume depletion

2.6

17.5

377

N05AX08

ATC

risperidone; systemic

1.8

17.5

288

1681

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

17.4

162

780

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

17.4

147

682

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

17.3

344

2113

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

17.3

333

2028

S80.0

ICD-10 Finland

Contusion of knee

1.8

17.3

266

1520

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.3

17.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

17.3

1440

11744

H36.01

ICD-10 Finland

Diabetic maculopathy

3.4

17.2

181

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

17.2

115

482

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

17.2

1465

11988

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

3.8

17.1

139

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

17.1

185

942

M03BX02

ATC

tizanidine; oral

1.3

17.1

2261

19692

M05BA04

ATC

alendronic acid; oral

1.8

17.1

273

1579

ZZR00

NOMESCO Finland

Flap of skin

2.8

17.0

314

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

16.9

147

689

SPAT1125

SPAT

Stoma care and guidance

3.2

16.8

209

C10AC01

ATC

colestyramine; oral

2.5

16.8

101

403

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

16.8

368

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.8

16.8

132

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

16.8

139

640

A10BK01

ATC

dapagliflozin; oral

1.8

16.7

244

1373

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

16.7

172

861

N06AA12

ATC

doxepin; systemic

2.0

16.7

180

916

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

16.7

253

1440

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

16.7

835

6264

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

16.7

257

6861A

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Pyogenic granuloma

+∞

16.7

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

+∞

16.7

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

35.2

16.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

16.7

528

3626

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.0

16.7

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

16.6

803

5988

R06AE09

ATC

levocetirizine; oral

1.5

16.6

517

3538

H05BX01

ATC

cinacalcet; oral

4.8

16.6

J05AB11

ATC

valaciclovir; oral

1.5

16.6

490

3315

C08CA02

ATC

felodipine; oral

1.7

16.5

310

1876

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

16.5

488

3301

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

16.5

828

6215

N19

ICD-10 Finland

Unspecified kidney failure

2.3

16.5

129

580

RS221, ,

NOMESCO Finland

3.1

16.5

222

OAB50, ,

SPAT

1.9

16.5

198

1047

TK810

NOMESCO Finland

Hemofiltration

5.1

16.4

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

16.4

272

1589

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

16.4

384

2459

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.4

16.4

167

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

16.4

208

1119

P29

ICPC

Psychological sympt/compl other

1.8

16.4

251

1433

WX204

NOMESCO Finland

Axillary plexus blockaced

2.3

16.4

126

562

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.2

16.4

131

594

L85.3

ICD-10 Finland

Xerosis cutis

3.8

16.3

130

H01

ICPC

Ear pain/earache

1.6

16.3

404

2623

B03XA01

ATC

erythropoietin; parenteral

4.1

16.3

108

SPAT1252

SPAT

Overall medication plan or its review

1.8

16.2

233

1304

WX872

NOMESCO Finland

Intensive care

2.0

16.2

187

974

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.8

16.2

294

E87.6

ICD-10 Finland

Hypokalaemia

2.3

16.2

125

558

L30.8

ICD-10 Finland

Other specified dermatitis

2.5

16.2

104

428

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.2

749

5538

N02AC04

ATC

dextropropoxyphene; oral

2.3

16.2

127

572

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

16.1

747

5523

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.9

16.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

16.1

107

448

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.3

16.1

121

535

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

16.0

129

587

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

16.0

169

854

R03BA02

ATC

budesonide; inhalant

1.5

16.0

622

4451

C01DA14

ATC

isosorbide mononitrate; oral

1.5

16.0

498

3406

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

15.9

191

1009

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.5

15.9

156

R31

ICD-10 Finland

Unspecified haematuria

1.6

15.9

352

2225

Z50.1

ICD-10 Finland

Other physical therapy

1.9

15.8

192

1018

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

15.8

234

1322

M01AE02

ATC

naproxen; oral, rectal

1.3

15.8

2074

17960

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

15.8

412

2707

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

12.2

15.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

15.8

291

1752

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

5.2

15.8

M02AA07

ATC

piroxicam; topical

1.3

15.8

1217

9781

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

15.7

313

1924

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

15.7

933

7196

R55

ICD-10 Finland

Syncope and collapse

1.6

15.7

367

2349

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.3

15.7

172

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

15.7

196

1050

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.5

15.7

148

SPAT1234

SPAT

Support of social functional capacity

1.9

15.6

185

973

SPAT1167

SPAT

Insertion of urinary catheter

2.3

15.6

113

492

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

15.5

256

1495

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

15.5

148

721

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

15.5

231

1309

L40.8

ICD-10 Finland

Other psoriasis

4.1

15.4

104

R03BA05

ATC

fluticasone; inhalant

1.5

15.4

637

4611

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

15.4

466

3167

-, ,

ICD-10 Finland

2.6

15.4

349

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

15.2

473

3232

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

15.2

202

1104

A01AB09

ATC

miconazole; local oral

1.7

15.2

286

1732

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

1274

4285

3.84

318.98

3.2

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1288

3599

4.73

307.65

2.9

1.6

—

(3023368) Bacteria identified in Blood by Culture

1860

8552

3.12

273.66

6.6

4.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2392

15756

2.21

133.19

9.3

6.3

—

(3006315) Basophils [#/volume] in Blood

2503

16795

2.22

132.95

9.1

5.8

0.04

e9/l

0.63

2209

14506

(3001604) Monocytes [#/volume] in Blood

2499

16767

2.22

132.63

9.1

5.8

0.60

0.58

e9/l

3.36

2208

14491

(3019198) Lymphocytes [#/volume] in Blood

2551

17280

2.22

131.87

9.1

5.8

1.83

1.94

e9/l

4.08

2311

15297

(3013115) Eosinophils [#/volume] in Blood

2559

17387

2.22

130.84

9.5

6.0

0.21

0.19

e9/l

3.66

2300

15257

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2497

16924

2.18

126.75

8.5

6.1

10.54

11.79

umol/l

5.86

2409

16050

(3013650) Neutrophils [#/volume] in Blood by Automated count

2750

19396

2.22

125.71

13.2

8.8

4.34

4.08

e9/l

6.90

2457

16890

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1069

5181

2.43

123.29

2.4

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2741

19406

2.20

122.65

8.6

4.6

7.05

6.66

mmol/l

10.82

2612

18131

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2388

16086

2.13

120.77

13.0

6.7

1.21

mmol/l

4.34

2113

13692

(3006504) Eosinophils/100 leukocytes in Blood

2328

15721

2.09

114.56

9.3

6.0

2.87

2.85

0.18

2205

14710

(3019069) Monocytes/100 leukocytes in Blood

2337

15827

2.08

113.83

9.7

6.3

8.64

8.62

0.11

2218

14849

(3022096) Basophils/100 leukocytes in Blood

2272

15247

2.08

113.22

9.2

6.1

0.66

0.67

0.32

2152

14248

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2199

14582

2.07

113.21

11.5

6.0

1.20

1.21

mmol/l

3.34

2061

13331

(3021447) Carbon dioxide [Partial pressure] in Venous blood

729

3068

2.67

112.30

8.4

4.1

5.89

5.84

kpa

0.67

709

2973

(3022217) INR in Platelet poor plasma by Coagulation assay

2236

14962

2.06

111.78

19.8

14.6

1.26

1.27

inr

0.11

590

4404

(3018010) Neutrophils/100 leukocytes in Blood

2353

16051

2.07

111.44

9.1

5.9

58.80

56.88

12.07

2235

15079

(3002030) Lymphocytes/100 leukocytes in Blood

2376

16303

2.06

110.27

9.4

6.1

26.18

28.20

15.72

2258

15334

(3024561) Albumin [Mass/volume] in Serum or Plasma

2118

13961

2.05

109.59

8.3

4.9

34.33

35.74

g/l

22.17

2007

12983

(3002032) Base excess in Venous blood by calculation

721

3058

2.64

109.10

8.7

4.1

1.90

1.91

mmol/l

0.01

643

2548

(3012544) pH of Venous blood

736

3172

2.60

107.69

8.5

4.0

7.35

7.37

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1008

5055

2.31

105.41

4.2

2.4

11.42

13.40

umol/l

15.49

954

4714

(3004789) Transferrin [Mass/volume] in Serum or Plasma

950

4651

2.35

105.03

4.3

2.4

2.26

2.34

g/l

3.56

893

4302

(3020779) Urea [Moles/volume] in Serum or Plasma

692

2935

2.63

104.38

14.0

7.4

11.22

9.39

mmol/l

8.38

663

2802

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

901

4349

2.37

102.65

4.4

2.5

20.54

23.31

7.63

782

3716

(3014111) Lactate [Moles/volume] in Serum or Plasma

667

2821

2.62

100.96

10.6

7.2

1.30

1.36

mmol/l

0.84

654

2742

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

777

3545

2.46

100.18

2.2

1.7

—

(3000991) Gas panel - Venous blood

658

2776

2.63

100.04

13.4

8.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

770

3568

2.42

95.55

2.2

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

567

2277

2.72

94.82

1.9

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1001

5244

2.20

92.62

5.4

3.6

0.80

0.82

mmol/l

5.36

946

4922

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3207

25409

2.13

90.62

11.6

7.2

82.22

78.26

u/l

5.06

3076

23989

(3024354) Oxygen [Partial pressure] in Venous blood

598

2535

2.59

89.40

7.0

3.6

4.85

4.64

kpa

1.38

578

2453

(3003458) Phosphate [Moles/volume] in Serum or Plasma

857

4270

2.27

89.33

12.7

6.0

1.10

1.05

mmol/l

4.84

818

3983

(3026008) Bacteria identified in Urine by Culture

1529

9543

1.95

86.59

4.0

3.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2843

21775

1.96

85.48

6.5

4.2

1735.68

1512.82

e6/l

0.05

291

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1598

10175

1.92

84.82

3.8

2.5

57.43

67.33

u/l

0.65

1503

9405

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1239

7243

2.01

84.40

2.2

1.8

1.27

1.23

mg/l

0.14

978

5467

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1368

8303

1.96

83.46

3.0

2.2

3.03

2.92

mg/l

1.14

1218

7062

(3000494) Fungus identified in Specimen by Culture

773

3813

2.26

81.87

1.7

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1608

10404

1.89

80.10

3.7

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2182

15567

1.84

79.22

3.7

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1515

9655

1.89

78.79

2.8

2.1

196.91

227.87

u/l

0.76

1446

9074

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1001

5548

2.06

78.18

3.7

2.7

1.31

1.17

e6/l

0.34

612

3132

(3030467) Casts [#/volume] in Urine by Automated count

1448

9125

1.90

77.73

4.8

3.1

0.45

0.40

e6/l

0.29

1155

6927

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

458

1826

2.69

76.95

2.0

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1546

9981

1.87

76.73

4.9

3.2

98.24

92.76

e6/l

0.03

1236

7650

(3018095) Leukocytes [#/volume] in Urine

1734

11675

1.83

74.63

5.6

3.6

114.83

100.44

e6/l

0.14

1312

8229

(3037467) Urinalysis macro (dipstick) panel - Urine

2911

22938

1.89

74.46

6.2

4.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

456

1855

2.64

73.46

1.8

1.5

—

(3018418) pH of Serum or Plasma

1464

9393

1.86

73.33

7.5

3.9

7.39

7.40

2.34

254

1821

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

939

5206

2.04

72.59

3.9

2.9

2.96

2.34

e6/l

1.04

554

2811

(3027801) Oxygen [Partial pressure] in Arterial blood

725

3649

2.19

72.29

10.3

7.5

12.08

12.50

kpa

1.38

689

3473

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

725

3651

2.19

72.19

10.3

7.5

5.15

5.08

kpa

1.01

691

3474

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

424

1680

2.70

71.94

10.7

4.5

24.14

24.06

mmol/l

0.19

418

1647

(3003396) Base excess in Arterial blood by calculation

721

3641

2.18

71.20

10.4

7.5

0.83

1.05

mmol/l

0.77

590

2853

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1278

7964

1.87

69.42

3.6

2.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1379

8801

1.85

69.41

3.8

3.0

2339.07

1350.43

ng/l

4.29

1194

7491

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1858

12969

1.78

69.31

2.3

1.9

95.23

pmol/l

0.00

1013

6865

(3013707) Erythrocyte sedimentation rate by Westergren method

3047

24637

1.88

68.43

5.5

3.9

15.14

11.44

mm/h

24.34

2863

22848

(36304419) Bacteria [Presence] in Urine

1389

8924

1.83

68.16

4.7

3.0

—

(40758558) Short blood count panel - Blood

1327

8425

1.84

67.56

10.4

6.6

—

(3016502) Oxygen saturation in Arterial blood

652

3251

2.19

66.10

10.9

7.9

95.46

95.79

0.67

629

3129

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

168

397

4.37

64.84

8.4

6.8

12.11

11.70

mg/l

0.54

160

371

(3009508) Creatinine [Moles/volume] in Urine

1517

10134

1.78

64.53

4.6

3.2

7.23

7.82

mmol/l

5.53

1295

8615

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

612

3010

2.21

64.06

2.9

2.3

0.21

0.22

g/l

2.15

566

2813

(3004119) Hemoglobin [Mass/volume] in Venous blood

447

1925

2.48

63.58

6.9

3.5

122.91

129.70

g/l

7.16

439

1871

(3033658) Prothrombin time (PT) actual/Normal

1309

8405

1.81

63.41

7.0

4.0

88.22

89.89

1.51

1284

8193

(3021960) Folate [Moles/volume] in Serum or Plasma

1173

7298

1.84

62.92

1.7

1.5

20.33

20.30

nmol/l

0.02

1025

6259

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1592

10878

1.75

61.96

4.4

3.2

32.39

35.75

u/l

0.96

1513

10353

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

702

3702

2.08

61.16

4.4

4.3

245.03

243.79

u/l

0.06

683

3494

(3018677) aPTT in Platelet poor plasma by Coagulation assay

880

5055

1.94

60.07

2.9

2.2

29.99

29.74

0.61

852

4895

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

295

1061

2.92

59.85

2.6

2.3

644.03

465.86

ug/l

0.40

282

989

(3002173) Hemoglobin [Mass/volume] in Arterial blood

601

3011

2.16

59.79

11.3

8.2

119.32

122.84

g/l

3.62

589

2925

(3027945) Reticulocytes/100 erythrocytes in Blood

685

3628

2.06

58.80

3.3

2.7

1.81

1.76

0.57

621

3217

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1987

14574

1.69

58.72

4.3

2.8

130.89

124.02

ug/l

0.62

1879

13511

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1851

13326

1.70

58.62

3.2

2.2

73.84

76.38

nmol/l

3.66

1694

12029

(3026493) Urate [Moles/volume] in Serum or Plasma

1303

8555

1.76

57.34

3.8

2.7

2311.57

4766.54

umol/l

2.27

1143

7541

(3000850) Epithelial cells [#/volume] in Urine

1104

6909

1.81

57.18

3.7

2.5

6.05

5.48

e6/l

0.56

999

6194

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

195

573

3.52

55.39

1.8

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3807

33985

2.37

55.35

29.9

13.1

25.26

23.49

mg/l

2.96

3380

26574

(3026250) Tacrolimus [Mass/volume] in Blood

150

6.32

55.19

35.2

33.7

7.06

7.38

ug/l

0.53

135

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

258

902

2.98

55.02

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

717

3955

1.98

54.60

2.2

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

491

2351

2.23

54.40

7.4

4.1

119.25

87.55

ng/l

5.40

441

2051

(3026782) Osmolality of Urine

1052

6595

1.80

53.63

4.1

2.8

522.10

550.66

mosm/kgh2o

4.28

935

5653

(3015736) pH of Urine

1800

13102

1.66

52.93

4.5

3.2

5.87

5.85

0.08

104

1053

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

253

896

2.94

52.69

2.1

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

315

1255

2.63

52.41

2.2

1.9

1.81

2.28

ug/l

0.38

284

1107

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1001

6288

1.78

50.19

5.4

3.6

238.94

616.86

ng/l

1.43

778

4790

(3020682) Albumin/Creatinine [Ratio] in Urine

1410

9744

1.68

49.95

4.7

3.8

18.02

8.66

mg/mmol

4.60

956

6225

(3012516) Albumin [Mass/volume] in Urine

1355

9278

1.68

49.65

4.1

3.2

496.08

320.88

mg/l

0.68

969

5975

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1678

12155

1.64

49.21

5.0

3.4

42.56

54.39

ng/l

0.67

1236

8058

(3023520) Reticulocytes [#/volume] in Blood

526

2688

2.09

49.12

3.1

2.7

68.82

69.28

e9/l

0.10

385

2042

(3036481) Cortisol [Moles/volume] in Serum or Plasma

578

3059

2.03

49.09

2.5

2.2

357.91

370.14

nmol/l

0.73

542

2803

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

335

1430

2.46

48.16

1.8

1.7

1.71

1.51

g/l

2.93

296

1227

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

325

1370

2.49

48.01

5.7

3.9

51.43

49.03

0.89

320

1354

(3035350) Ketones [Presence] in Urine by Test strip

2110

16242

1.60

47.68

4.8

3.5

0.01

0.00

estimate

0.46

392

3237

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

444

2151

2.19

47.51

5.9

4.3

5.21

5.14

kpa

0.84

430

2055

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

372

1676

2.34

47.38

13.1

9.6

24.09

24.28

mmol/l

0.58

356

1630

(3019309) Folate [Moles/volume] in Red Blood Cells

925

5763

1.78

47.33

1.9

1.7

1222.54

1164.83

nmol/l

0.93

739

4363

(3011397) Hemoglobin [Presence] in Urine by Test strip

1145

7577

1.70

47.24

4.6

3.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

2105

16218

1.60

47.20

6.6

4.7

0.00

estimate

0.80

373

3091

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

427

2050

2.21

46.70

5.9

4.3

1.69

1.65

mmol/l

0.07

333

1517

(3009445) Proteinase 3 Ab [Units/volume] in Serum

323

1375

2.46

46.68

1.6

1.5

24.04

17.90

u/ml

—

(40768443) Skin Pathology biopsy report

318

1347

2.47

46.45

1.4

1.2

—

(3021589) Normoblasts [#/volume] in Blood

1956

14856

1.60

46.24

15.2

9.2

0.00

e9/l

0.01

1601

12081

(3009343) pH of Capillary blood

436

2125

2.17

45.89

6.0

4.3

7.40

7.41

0.50

232

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

268

1054

2.65

45.67

3.5

3.7

0.32

0.35

u/ml

0.57

149

611

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

656

3725

1.90

45.12

4.0

2.9

6.59

8.22

umol/l

2.21

587

3239

(3027273) Bicarbonate [Moles/volume] in Venous blood

337

1485

2.38

45.09

6.3

3.4

25.17

25.24

mmol/l

0.13

330

1434

(3009261) Glucose [Presence] in Urine by Test strip

2111

16396

1.58

44.83

4.9

3.5

0.00

estimate

1.47

349

2974

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

570

3104

1.97

44.36

3.5

2.4

32.61

52.15

u/l

0.69

497

2671

(3014007) Fractional oxyhemoglobin in Arterial blood

409

2001

2.16

42.52

13.5

9.2

93.52

94.09

1.11

409

1993

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

370

1750

2.22

41.84

13.9

10.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

166

527

3.24

41.68

3.8

3.4

279.82

1434.37

u/ml

1.14

(3021879) Hepatitis B virus core Ab [Presence] in Serum

485

2578

2.00

40.25

1.7

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3790

34527

2.06

40.07

32.4

15.1

139.29

139.66

mmol/l

15.80

3712

33624

(3037522) Nuclear Ab [Titer] in Serum

729

4431

1.78

39.83

1.4

1.3

529.58

535.78

titre

0.03

142

925

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

678

2.90

39.54

8.5

5.6

271.97

629.54

iu/ml

0.79

(3023103) Potassium [Moles/volume] in Serum or Plasma

3795

34637

2.05

39.15

32.7

15.2

3.99

3.97

mmol/l

4.93

3716

33667

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

830

5282

1.71

38.41

2.0

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1470

10846

1.55

36.89

4.5

3.3

2.35

mmol/l

0.75

1295

9591

(3023183) Ammonium ion [Moles/volume] in Plasma

188

688

2.81

36.78

3.1

3.0

31.46

36.73

umol/l

1.87

168

627

(3020630) Protein [Mass/volume] in Serum or Plasma

468

2556

1.94

35.70

3.4

2.7

65.54

66.56

g/l

2.03

432

2350

(3024928) Oxygen saturation in Venous blood

187

694

2.77

35.63

7.9

3.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2975

25646

1.56

35.03

4.5

3.9

14.62

14.72

pmol/l

1.37

2719

23363

(3019060) Gas panel - Arterial blood

397

2083

2.00

33.96

6.1

5.0

—

(3022313) Gas panel - Capillary blood

326

1593

2.14

33.79

6.0

4.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

178

662

2.76

33.78

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

178

662

2.76

33.78

1.6

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

223

928

2.48

33.72

4.3

3.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

156

4.81

32.94

26.3

27.0

109.49

120.25

ug/l

0.69

132

(46235355) HIV 1 and 2 tests - Meaningful Use set

947

6510

1.59

31.52

2.4

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

551

3295

1.77

31.26

5.4

3.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

273

1290

2.19

30.76

6.0

5.7

1.89

1.64

2.48

259

1202

(3005719) IgG [Mass/volume] in Serum or Plasma

450

2547

1.86

30.57

3.2

2.7

10.70

10.53

g/l

0.32

418

2326

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3427

30851

1.62

30.29

5.6

4.5

1.93

2.04

mu/l

0.76

3180

28349

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

178

701

2.61

30.19

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

241

1091

2.28

30.13

3.4

3.0

89.84

91.58

0.54

230

1055

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

236

1060

2.30

30.06

1.6

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

137

4.88

29.94

1.1

6.14

4.13

iu/ml

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

287

1400

2.13

29.82

6.5

4.7

24.85

24.72

mmol/l

0.28

276

1312

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

466

2690

1.82

29.67

3.6

2.9

252.67

185.36

ng/l

2.25

422

2435

(3007930) Methemoglobin/Hemoglobin.total in Blood

269

1282

2.17

29.66

6.1

5.7

0.89

0.90

0.19

256

1197

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

223

985

2.34

29.52

3.6

2.9

200.26

186.27

1.48

216

941

(3008152) Bicarbonate [Moles/volume] in Arterial blood

369

1997

1.93

28.71

9.1

7.0

24.60

24.48

mmol/l

0.22

350

1892

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

467

2737

1.80

28.22

2.8

2.3

6.54

7.29

ug/l

0.37

413

2408

(3036489) Thrombin time

265

1281

2.14

28.17

3.0

2.5

22.13

21.35

1.32

231

1130

(3028707) Methadone [Presence] in Urine by Screen method

153

583

2.69

27.72

6.4

2.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

213

949

2.31

27.64

9.2

5.1

1.86

1.44

mg/l

5.99

199

878

(3007164) IgA [Mass/volume] in Serum or Plasma

945

6669

1.54

27.48

1.6

1.5

2.53

2.39

g/l

1.16

582

4129

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.23

27.38

12.1

5.51

6.14

mmol/l

0.46

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2629

22585

1.44

27.29

4.5

3.0

55.72

46.92

u/l

4.94

2500

21128

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

224

1026

2.25

27.22

3.9

3.1

3.87

3.50

g/l

2.52

215

968

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

174

714

2.50

27.11

1.9

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

172

708

2.49

26.62

1.7

25191.01

12071.39

e6/l

1.31

112

508

(3019150) Specific gravity of Urine by Refractometry

987

7087

1.51

26.31

5.3

3.8

1.02

kg/l

0.88

135

1052

(3044941) Cell count panel - Synovial fluid

129

463

2.84

26.21

1.6

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

635

4137

1.63

25.88

2.6

2.4

161.35

138.57

ug/g

0.61

519

3306

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

120

4.80

25.46

2.1

1.5

2747020.00

1309812.50

iu/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

373

2107

1.85

25.34

1.5

1.3

680.56

206.44

u/ml

2.00

347

1945

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3462

31578

1.56

25.25

23.9

12.3

81.64

82.89

ml/min/173m2

2.02

2975

25936

(3048929) Epstein Barr virus Ab [Presence] in Serum

240

1169

2.12

25.00

1.5

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

185

3.94

24.94

1.6

1.5

—

(40761535) Cells panel - Urine sediment

444

2657

1.75

24.85

4.8

3.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

172

733

2.40

24.70

1.6

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

218

1031

2.18

24.49

2.7

—

(3021788) Differential panel - Synovial fluid

136

523

2.65

24.23

1.7

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

355

2004

1.84

24.14

2.1

1.9

1.24

1.36

g/l

0.34

330

1835

(3028626) Oxygen [Partial pressure] in Capillary blood

193

876

2.26

23.98

5.4

4.8

8.65

8.50

kpa

0.50

186

857

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

158

657

2.46

23.95

2.0

1.5

115.70

116.61

u/ml

0.03

120

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

263

1349

2.01

23.82

2.5

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

366

2095

1.82

23.79

2.9

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

244

1224

2.06

23.50

2.3

1.8

—

(40761511) CBC panel - Blood by Automated count

3787

35457

1.73

23.18

24.8

12.4

—

(3042733) HLA Ab [Presence] in Serum

114

4.70

23.10

4.7

4.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3340

30390

1.50

23.00

7.8

5.4

42.23

39.36

mmol/mol

35.22

3109

28212

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

195

906

2.21

22.90

4.1

3.5

6.88

2.38

ratio

0.38

(3034860) Kappa light chains.free [Mass/volume] in Serum

197

930

2.17

22.24

4.2

3.5

77.00

120.04

mg/l

0.30

168

754

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2578

22448

1.39

22.20

3.5

3.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

168

745

2.31

22.06

1.5

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

205

989

2.13

21.90

2.0

1.6

1.18

1.17

g/l

0.09

191

940

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

196

930

2.16

21.84

4.3

3.5

37.79

67.72

mg/l

1.20

166

757

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

161

705

2.34

21.77

1.6

1.3

285.09

258.53

u/ml

0.54

116

430

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

427

2619

1.70

21.77

4.3

2.5

60.03

67.42

ml/min/173m2

2.63

182

1014

(3011648) Oxygen content in Venous blood

274

3.18

21.58

8.9

4.1

10.82

11.33

0.47

274

(3025941) Bacteria identified in Stool by Culture

328

1874

1.81

21.40

1.4

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

198

952

2.13

21.34

2.1

1.6

0.24

0.23

g/l

0.32

181

905

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

620

4191

1.56

21.33

2.0

1.7

1.60

1.45

5.22

530

3709

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

175

801

2.24

21.32

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

240

3.29

20.73

1.3

—

(3020891) Body temperature

242

1270

1.96

20.53

6.7

4.5

—

(3017181) Myelocytes/100 leukocytes in Blood

441

2774

1.66

20.39

4.8

4.2

0.93

0.00

198

918

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1001

7557

1.43

19.75

1.4

1.3

1.16

1.75

u/ml

1.52

244

1990

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

179

3.62

19.71

1.4

1.3

176.00

499.44

titre

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

186

905

2.10

19.45

1.4

241.59

282.94

ug/g

1.88

109

513

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

170

800

2.17

19.36

1.9

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

261

3.11

19.33

1.9

1.4

1.16

1.27

promille

0.24

203

(3037121) Protein [Mass/volume] in Urine

222

1157

1.97

19.22

5.6

3.5

0.47

0.32

g/l

0.84

126

498

(3037756) Immunofixation for Serum or Plasma

140

615

2.32

18.83

2.0

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.93

18.68

6.0

6.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

767

5564

1.46

18.61

1.3

42.38

32.03

iu/ml

0.46

223

1769

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

206

3.34

18.56

1.9

1.4

24.64

20.80

u/ml

0.34

(3011288) Drugs identified in Urine by Screen method

189

944

2.05

18.44

6.2

2.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

121

503

2.45

18.42

2.8

3.5

1.18

1.38

0.34

108

446

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

132

3.98

18.39

1.1

222.14

225.54

iu/ml

0.03

132

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

164

781

2.14

18.14

1.9

1.6

—

(3021901) Oxygen saturation in Capillary blood

130

565

2.34

17.93

3.9

2.8

—

(3013512) EKG study

1168

9189

1.38

17.77

4.9

3.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3814

36140

1.64

17.70

16.6

9.8

26.74

26.84

u/l

0.11

3723

34872

(3047181) Lactate [Moles/volume] in Blood

202

1054

1.96

17.44

7.4

6.5

1.30

1.31

mmol/l

0.05

185

924

(3036180) Methadone [Presence] in Urine

156

3.62

17.38

3.3

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1100

1.94

17.27

2.8

2.4

10.42

10.22

g/l

0.25

185

994

(3000330) Specific gravity of Urine by Test strip

274

1584

1.78

17.16

4.4

3.3

—

(40768804) Tissue Pathology biopsy report

1606

13322

1.33

17.13

2.4

2.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

114

477

2.43

17.13

1.4

1.2

—

(3017732) Neutrophils [#/volume] in Blood

361

2255

1.66

17.07

3.6

2.8

5.01

5.29

e9/l

0.20

278

1856

(4200892) Spirometry reversibility

359

2246

1.65

16.87

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

892

6761

1.41

16.83

1.8

1.7

446.15

30906632.39

pmol/l

5.21

750

5672

(40768446) Kidney Pathology biopsy report

137

3.76

16.70

1.9

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

146

689

2.16

16.55

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1176

1.88

16.43

2.9

2.3

3.92

3.66

g/l

1.11

195

1078

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1177

1.88

16.39

2.9

2.3

7.53

7.36

g/l

0.77

195

1078

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

216

1177

1.88

16.39

2.9

2.3

—

(3044889) 12 lead EKG panel

2591

23080

1.32

16.33

4.5

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1522

12594

1.33

16.28

5.2

3.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

146

699

2.13

15.97

4.7

3.7

—

(3024471) HLA-A [Type]

119

3.90

15.89

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

204

1103

1.89

15.86

5.3

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

377

2.53

15.49

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

383

2.51

15.49

1.6

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

302

2.72

15.45

1.3

1.1

62.86

74.22

u/l

0.50

273

(3021440) Promyelocytes/100 leukocytes in Blood

402

2644

1.58

15.36

5.1

4.2

0.12

0.08

166

791

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

125

572

2.22

15.32

1.9

1.7

—

(3024932) HLA-DR beta [Type]

118

3.84

15.27

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

104

441

2.39

15.22

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

381

2.50

15.16

1.5

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

1035

1.90

15.08

1.6

0.73

6.53

iu/ml

0.51

212

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

138

3.58

15.01

4.8

1.8

152.04

160.89

umol/l

0.06

(3002385) Erythrocyte distribution width [Ratio]

3195

29498

1.35

14.81

33.3

15.8

14.89

0.01

3156

28925

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

769

5797

1.40

14.75

3.3

3.0

2.46

2.45

mmol/l

2.42

658

5082

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

181

965

1.92

14.70

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

5.30

14.64

1.3

1.1

—

(3025159) Blasts/100 leukocytes in Blood

380

2498

1.57

14.53

5.1

4.2

0.13

0.38

0.73

139

650

(3017354) Segmented neutrophils/100 leukocytes in Blood

313

2.62

14.43

3.1

3.5

62.52

55.75

2.12

265

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

120

554

2.20

14.41

1.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

120

554

2.20

14.41

1.9

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

150

755

2.02

14.39

2.6

2.2

163.94

99.12

ug/min

0.85

472

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

709

5294

1.41

14.34

1.3

1.2

14.94

12.19

u/ml

0.37

225

2084

(3014765) Yersinia sp identified in Stool by Organism specific culture

181

976

1.89

14.21

1.3

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1102

1.84

14.08

3.0

2.4

3.07

2.96

g/l

0.65

178

1003

(3002179) Metamyelocytes/100 leukocytes in Blood

383

2543

1.56

14.01

4.6

4.0

0.83

0.72

0.26

165

797

(3045414) Leukocytes [Presence] in Urine

243

1442

1.73

13.91

2.5

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

200

1125

1.82

13.75

5.4

3.7

1.42

1.39

mmol/l

0.21

195

1110

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

895

1.91

13.70

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

370

2.44

13.64

2.1

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

103

457

2.29

13.63

2.0

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

180

984

1.87

13.56

1.3

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

584

2.12

13.40

1.8

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

271

1673

1.66

13.39

3.4

2.7

0.19

0.27

e6/l

1.13

265

1626

(3039000) Anion gap in Blood

143

731

1.99

13.16

8.5

7.7

11.56

11.29

mmol/l

0.33

132

650

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

135

676

2.03

13.16

1.2

1.92

5.91

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

106

484

2.22

13.11

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

143

732

1.99

13.11

8.5

7.7

104.69

105.19

mmol/l

0.53

132

651

(3016879) Cocaine [Presence] in Urine

223

1314

1.74

13.10

5.7

1.9

—

(3019225) pH of Specimen

452

3154

1.49

13.07

6.6

4.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

265

1643

1.65

12.89

2.6

2.4

—

(3049717) Cytology report of Urine Cyto stain

208

1212

1.75

12.71

2.7

2.6

—

(3003181) Sodium [Moles/volume] in Urine

114

543

2.13

12.70

2.4

1.4

59.90

63.73

mmol/l

0.38

440

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

134

681

2.00

12.55

4.4

1.8

0.78

0.83

nmol/l

0.30

100

573

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

373

2.36

12.49

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

373

2.36

12.49

1.6

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

350

2.40

12.36

3.6

4.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

375

2.35

12.34

1.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

152

3.18

12.31

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

291

2.54

12.26

1.4

1.3

1.30

1.49

nmol/l

0.79

260

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

354

2.37

12.07

1.6

1.7

—

(1616796) Gas panel - Central venous blood

137

712

1.96

12.06

6.4

3.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

393

2.29

11.96

2.5

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

331

2.41

11.95

3.5

2.5

1.06

1.54

g/24h

0.88

166

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

332

2.41

11.87

1.5

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3424

32237

1.35

11.84

5.3

4.3

6.20

5.89

mmol/l

19.73

3169

29467

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

106

505

2.13

11.83

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

133

689

1.96

11.82

3.0

2.2

129.20

130.30

g/l

0.17

501

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

454

2.19

11.74

1.7

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

178

1015

1.79

11.73

3.0

2.4

0.72

0.99

g/l

0.52

152

885

(40768797) Stomach Pathology biopsy report

599

4487

1.39

11.72

1.4

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

165

922

1.82

11.63

2.8

2.2

35.47

37.84

g/l

4.86

144

822

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

152

830

1.86

11.54

2.9

2.3

0.00

g/l

-0.00

142

773

(3029937) Albumin [Presence] in Urine by Test strip

1070

8757

1.30

11.50

5.5

3.9

0.00

estimate

0.06

351

2968

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

123

3.36

11.48

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3936

38035

1.61

11.44

41.1

19.5

39.33

40.61

8.99

3691

35695

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

101

479

2.14

11.42

1.2

1.1

117.91

114.90

0.37

437

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

129

3.28

11.34

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

176

2.92

11.32

2.5

1.5

13.89

25.90

umol/l

3.38

166

(36660697) Celiac disease serology panel - Serum

390

2718

1.48

11.32

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

150

822

1.86

11.27

2.9

2.3

0.00

g/l

-0.00

141

772

(3000764) Benzodiazepines [Presence] in Urine

229

1418

1.65

11.21

5.6

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

159

889

1.82

11.20

3.0

2.3

0.00

0.03

g/l

2.00

149

829

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1050

8606

1.29

11.10

1.9

1.6

1.51

1.38

mmol/l

3.75

938

7278

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

537

3985

1.40

11.08

10.7

6.6

—

(3028300) Cannabinoids [Presence] in Urine

230

1432

1.64

11.02

5.6

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

127

665

1.94

10.97

1.6

1.5

—

(3027008) Opiates [Presence] in Urine

229

1427

1.64

10.94

5.5

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

370

2.27

10.94

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

3935

38063

1.59

10.89

40.4

19.4

254.23

250.34

e9/l

2.87

3863

37067

(3015171) Extractable nuclear Ab [Units/volume] in Serum

204

1237

1.68

10.83

1.2

1.3

0.57

0.98

u/ml

0.46

106

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

443

3190

1.43

10.83

3.8

4.0

20.66

22.94

ug/l

0.06

357

2584

(3035941) MCH [Entitic mass]

3936

38086

1.59

10.74

40.2

19.3

30.14

30.28

4.56

3882

37540

(3024731) MCV [Entitic volume]

3936

38086

1.59

10.74

40.3

19.3

90.88

90.76

0.88

3882

37544

(3010813) Leukocytes [#/volume] in Blood

3936

38088

1.59

10.72

40.4

19.4

7.09

6.72

e9/l

18.41

3850

36983

(3026361) Erythrocytes [#/volume] in Blood

3936

38092

1.58

10.66

40.4

19.4

4.41

4.52

e12/l

33.35

3856

36993

(3000963) Hemoglobin [Mass/volume] in Blood

3937

38104

1.59

10.66

40.7

19.5

131.69

136.19

g/l

58.78

3884

37562

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

293

2.41

10.65

3.6

2.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

102

501

2.06

10.55

1.5

1.2

4.19

4.64

u/ml

0.15

217

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

109

550

2.01

10.48

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

339

2.30

10.47

2.5

2.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

223

1397

1.63

10.44

1.8

1.9

38.76

38.84

u/l

0.02

196

1250

(3002256) Pathology report gross observation

562

4250

1.37

10.31

1.4

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

140

774

1.84

10.26

4.7

4.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

401

2.17

10.19

1.7

1.5

31.18

32.52

g/l

0.44

364

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

111

570

1.97

10.17

6.7

2.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

121

640

1.92

10.17

1.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

328

2263

1.49

10.01

2.4

27.73

23.11

au/ml

0.23

187

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

247

2.49

9.99

2.9

2.7

648.48

711.47

e6/l

0.45

238

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

806

6458

1.31

9.97

1.8

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

492

2.04

9.95

6.3

5.5

376.49

365.38

umol/l

0.33

437

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

167

2.84

9.94

1.4

1.1

32.00

18.90

u/l

0.96

142

(40767503) Oxygen content in Capillary blood by calculation

124

670

1.88

9.78

4.2

2.4

16.03

16.33

0.34

326

(3042517) Benzodiazepines panel - Urine

8.73

9.76

2.9

2.4

—

(3012501) Base excess in Blood by calculation

133

738

1.83

9.65

7.9

4.1

2.87

2.54

mmol/l

0.78

500

(3016650) Hepatitis A virus Ab [Presence] in Serum

105

539

1.97

9.65

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

156

909

1.74

9.61

1.3

1.2

18.12

40.85

u/ml

0.75

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

102

3.35

9.57

2.9

2.1

101.67

65.38

ug/l

1.00

(3022493) Free Hemoglobin [Mass/volume] in Plasma

138

2.99

9.56

2.0

5.2

60.28

71.06

mg/l

0.42

104

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

177

2.73

9.49

1.4

1.1

104.49

87.59

u/l

0.45

153

(3012441) Differential panel - Pleural fluid

303

2.30

9.47

1.6

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

475

2.02

9.41

1.3

1.4

21.19

24.32

u/l

0.51

395

(3027944) Amphetamines [Presence] in Urine

220

1410

1.59

9.41

5.7

1.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

146

841

1.76

9.37

1.3

1.2

22.35

3.58

u/ml

0.42

(3010421) pH of Blood

150

872

1.75

9.32

7.9

4.0

7.41

7.42

2.75

133

791

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

269

2.36

9.23

1.3

1.2

215.00

171.02

titre

—

(3003327) Ova and parasites identified in Stool by Light microscopy

180

1104

1.66

9.20

1.8

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

149

871

1.74

9.09

2.0

13.07

11.19

mg/l

1.25

142

809

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

100

516

1.96

9.08

1.5

1.2

2.82

4.34

u/ml

0.76

175

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

300

2075

1.48

9.05

1.2

1.3

49.69

54.27

au/ml

0.14

113

(3032057) Clostridioides difficile [Presence] in Stool

3.99

9.04

2.1

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

146

851

1.74

9.00

1.3

25.39

6.56

u/ml

0.83

148

(3023199) Leukocytes [#/volume] in Pleural fluid

363

2.14

8.93

1.7

1.4

2064.75

2003.99

e6/l

0.03

273

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3349

31735

1.28

8.92

4.6

3.8

1.38

1.29

mmol/l

8.03

3107

29217

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

104

551

1.91

8.75

1.1

93.49

1013.18

iu/ml

0.50

135

(21494890) Protein electrophoresis panel - 24 hour Urine

308

2.23

8.71

2.2

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

169

2.68

8.62

4.0

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

204

1316

1.58

8.51

2.3

6851.48

5355.76

u/l

0.24

517

(3001964) Herpes simplex virus Ag [Presence] in Specimen

100

3.22

8.47

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

425

2.02

8.46

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

432

2.01

8.45

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

121

2.99

8.45

3.3

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

291

2029

1.47

8.44

3.3

3.4

4.38

4.51

pmol/l

1.72

267

1802

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

127

2.93

8.37

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

127

2.93

8.37

1.4

—

(3022145) Colonoscopy Study observation

473

3594

1.36

8.37

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

138

2.84

8.36

3.6

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

362

2633

1.41

8.35

7.4

3.6

1.22

1.23

mmol/l

0.25

327

2296

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3521

33647

1.30

8.32

5.5

4.6

2.59

2.76

mmol/l

25.98

3283

31185

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

162

2.67

8.21

1.2

1.1

3.71

27.94

u/ml

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

396

2.04

8.19

2.0

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

396

2.04

8.19

2.0

1.5

—

(3023419) Bacteria identified in Sputum by Culture

479

1.94

8.18

2.9

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

174

2.60

8.16

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

1036

12127

0.81

8.05

3.1

2.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

326

2.14

8.00

1.7

1.4

29096.76

84478.07

e6/l

1.39

196

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

448

1.96

7.99

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

176

2.57

7.99

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

320

2.14

7.96

1.7

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

151

922

1.66

7.90

1.2

1.3

57.00

95.18

titre

—

(4035726) Immunohistochemistry procedure

383

2841

1.38

7.87

1.6

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

255

1757

1.48

7.86

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

369

2.05

7.83

3.1

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

239

2.32

7.80

3.1

2.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

191

2.48

7.72

1.6

1.5

14.09

6.03

u/l

0.86

159

(21494755) Public health laboratory ask at order entry panel

243

3472

0.68

7.69

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

139

841

1.68

7.54

3.2

2.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

389

2.00

7.49

1.2

1.4

343.30

341.03

pmol/l

0.01

337

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

153

2.63

7.44

2.2

3.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

213

2.36

7.43

1.3

1.2

12.29

12.61

u/l

0.04

193

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.08

7.42

1.5

1.3

9.09

8.92

ug/l

0.08

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

2.82

7.41

2.9

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

161

1016

1.61

7.41

2.2

1.8

—

(3004775) Volume in Urine collected for unspecified duration

245

2.26

7.39

2.7

2.1

765.16

614.48

1.70

161

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3460

33100

1.26

7.36

5.1

4.2

4.43

4.65

mmol/l

31.26

3254

30864

(3024263) Appearance of Synovial fluid

154

2.61

7.35

1.2

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

164

1042

1.60

7.34

1.7

1.4

8.36

9.21

u/l

0.44

130

838

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3437

32860

1.26

7.31

5.0

4.2

1.37

1.44

mmol/l

20.14

3209

30471

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

513

1.85

7.29

1.7

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

247

2.24

7.25

4.1

2.7

518.13

524.16

e6/l

0.02

205

(3042111) Morphology [Interpretation] in Bone marrow Narrative

536

1.83

7.23

1.8

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

429

1.93

7.23

1.5

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.83

6.90

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

496

3902

1.31

6.88

4.7

4.3

32.10

32.16

0.04

370

2684

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

240

2.22

6.87

4.3

2.8

0.21

e9/l

0.03

206

(3027456) Digoxin [Moles/volume] in Serum or Plasma

105

604

1.76

6.87

3.3

3.2

0.85

0.82

nmol/l

0.26

470

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.45

6.83

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

160

2.51

6.83

1.5

1.9

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

280

2.12

6.82

1.4

1.3

361.47

341.40

u/l

0.10

269

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.09

6.76

1.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

475

3726

1.31

6.73

2.4

2.0

—

(3028433) Virus identified in Specimen by Culture

104

2.90

6.73

1.4

1.3

—

(40768806) Pleura Pathology biopsy report

315

2.05

6.73

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1039

8930

1.22

6.72

4.4

3.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

163

1060

1.56

6.64

1.4

1.3

155.77

221.07

miu/ml

1.68

493

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

110

650

1.71

6.56

3.8

3.6

57.45

57.46

0.00

110

650

(3023511) Choriogonadotropin [Units/volume] in Urine

111

660

1.70

6.48

1.5

1.3

—

(3045788) Cell count panel - Pleural fluid

286

2.08

6.47

1.7

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

310

2296

1.38

6.45

2.3

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

202

2.29

6.43

20.2

17.5

1377.00

1463.01

nmol/l

0.33

196

(3016038) Potassium [Moles/volume] in Urine

209

2.26

6.39

2.2

1.3

41.15

33.93

mmol/l

0.72

185

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

160

2.45

6.34

1.5

1.9

—

(3016750) Collection duration of Urine

185

2.34

6.31

2.7

2.0

515.03

489.56

min

1.05

136

(3042631) Mycobacterium sp identified in Specimen

415

1.87

6.26

3.2

2.8

—

(3003694) ABO and Rh group [Type] in Blood

1111

9667

1.20

6.25

1.5

—

(3011412) CD3 cells [#/volume] in Blood

338

1.97

6.25

3.8

2.6

1.17

1.20

e9/l

0.10

300

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

199

2.28

6.20

1.0

1.1

1.17

1.04

ratio

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

353

1.94

6.19

1.6

62.60

59.92

0.20

216

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

206

2.25

6.16

3.0

2.8

35.10

42.82

2.03

118

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

517

4150

1.28

6.14

2.5

2.0

—

(3007463) Buprenorphine [Presence] in Urine

12.53

6.08

6.0

9.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

234

2.15

6.03

1.9

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

134

855

1.59

5.96

2.2

1.5

499.91

537.83

mg/l

0.28

128

804

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

159

2.40

5.94

2.1

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

159

2.40

5.94

2.1

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.01

5.89

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

433

3416

1.30

5.88

1.9

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

169

1142

1.50

5.82

3.3

3.6

1598.23

4333.25

u/ml

0.51

149

979

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

320

1.95

5.77

3.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

136

879

1.57

5.74

2.2

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

300

1.98

5.73

2.1

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

252

1843

1.39

5.69

2.3

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

361

2792

1.32

5.67

2.9

2.2

12.16

12.81

nmol/l

0.81

325

2493

(3000060) B lymphocytes [#/volume] in Blood

109

2.67

5.65

5.8

2.4

150.53

229.27

e6/l

0.91

(3010144) Erythrocytes [#/volume] in Synovial fluid

288

1.99

5.64

1.4

211062.68

87057.28

e6/l

0.42

203

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

145

956

1.54

5.61

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

255

2.05

5.58

2.1

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

439

1.79

5.57

2.3

1.7

10346.67

974.12

titre

—

(3004616) Nuclear Ab [Presence] in Serum

410

1.82

5.56

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

141

926

1.54

5.56

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

536

1.71

5.55

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

122

2.55

5.53

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

122

2.55

5.53

1.5

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

539

1.70

5.45

1.7

1.6

0.68

0.82

g/l

0.70

420

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.96

5.41

29.9

6.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

107

665

1.63

5.34

1.3

1.2

33.48

39.12

u/ml

0.19

(3044290) Cell count panel - Cerebral spinal fluid

110

690

1.61

5.30

2.6

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

9.11

5.28

3.6

3.4

—

(3044927) Protein electrophoresis panel - Urine

310

1.92

5.24

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

296

1.94

5.24

1.5

1.4

6.41

6.38

mmol/l

0.03

276

(3003338) MCHC [Mass/volume]

3078

29379

1.18

5.22

36.3

16.8

331.09

332.93

g/l

22.10

3060

29138

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

157

2.30

5.18

4.9

2.0

25.83

28.69

umol/l

0.69

151

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

209

2.12

5.16

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

391

1.80

5.15

2.2

25.74

21.04

mg/l

0.30

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

145

2.36

5.14

1.2

1.1

1574.00

1499.52

miu/ml

0.14

145

(3011985) Renin [Units/volume] in Plasma

415

1.77

5.07

1.4

69.03

73.16

mu/l

0.05

367

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.33

5.07

3.5

3.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

238

2.03

5.04

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

238

2.03

5.04

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

238

2.03

5.04

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

287

1.93

5.00

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

212

2.09

4.99

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

240

2.01

4.93

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

240

2.01

4.93

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

254

1.98

4.92

4.5

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

241

2.00

4.88

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

124

2.43

4.87

1.5

2.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

112

2.51

4.87

1.3

1.2

0.29

g/l

0.02

(3027923) C peptide [Moles/volume] in Serum or Plasma

181

2.17

4.86

1.8

1.3

1.28

1.29

nmol/l

0.02

142

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.71

4.83

32.5

6.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

117

764

1.55

4.78

2.2

1.4

4.12

3.71

mmol/l

1.82

108

711

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

9.02

4.78

8.1

7.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

2.47

4.70

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

108

2.51

4.70

1.7

1.5

—

(3047189) Immunofixation for 24 hour Urine

145

2.29

4.69

1.2

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

239

1.98

4.63

1.9

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

281

1.90

4.63

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

281

1.90

4.63

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

281

1.90

4.63

1.5

1.7

—

(3008295) Osmolality of Serum or Plasma

346

1.80

4.62

1.2

1.5

278.66

280.43

mosm/kgh2o

0.28

257

(3021387) Prolactin [Units/volume] in Serum or Plasma

177

1267

1.41

4.59

1.8

1.7

331.15

296.04

mu/l

0.56

151

1144

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

148

2.24

4.49

1.0

1.1

89.70

91.77

0.15

116

(3051611) Lipemic interference index of Serum or Plasma

320

1.82

4.49

5.7

3.0

—

(3022621) pH of Urine by Test strip

275

2124

1.32

4.41

3.5

2.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.07

4.40

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

205

1517

1.37

4.38

1.6

1.4

27.38

26.54

iu/l

0.11

164

1271

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

203

2.03

4.37

1.2

1.1

—

(21494434) Karyotype in Bone marrow

297

1.83

4.24

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

240

1.93

4.24

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

121

2.32

4.17

1.1

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

115

2.36

4.15

3.9

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

292

1.83

4.15

1.1

—

(3000012) Reticulocyte production index

451

1.65

4.08

2.4

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

223

1.94

4.05

1.5

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

196

2.00

4.01

1.3

1.5

4.67

7.55

u/l

2.18

171

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

4.01

2.7

10.4

—

(3045424) Erythrocytes [Presence] in Urine

548

1.58

3.97

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

112

758

1.49

3.94

2.7

1.6

32.22

23.25

e6/l

0.20

587

(4062490) Immunoglobulin typing, IgG

327

1.75

3.93

1.4

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

112

759

1.49

3.92

2.8

1.6

4004.86

1176.66

e6/l

0.36

617

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

112

2.33

3.91

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

106

2.37

3.90

1.8

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

256

1.85

3.84

1.3

1.83

2.02

mmol/l

1.15

243

(3000093) Morphology [Interpretation] in Blood Narrative

315

1.76

3.82

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

271

1.82

3.82

1.7

1.5

27.87

31.19

0.28

164

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

214

1.92

3.81

2.0

1.4

—

(3045142) Bone marrow Pathology biopsy report

368

1.70

3.80

1.4

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.19

3.77

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

155

2105

0.73

3.75

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

272

2149

1.28

3.73

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

325

1.73

3.72

1.4

1.3

0.44

0.39

g/l

0.21

232

(3019977) pH of Arterial blood

168

2.03

3.69

4.1

2.7

7.41

7.42

0.27

(3027135) IgG subclass 1 [Mass/volume] in Serum

326

1.73

3.69

1.4

1.3

6.92

6.65

g/l

0.21

232

(3028192) IgG subclass 2 [Mass/volume] in Serum

326

1.73

3.69

1.4

1.3

2.73

2.96

g/l

0.41

233

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

250

3165

0.78

3.68

1.7

—

(3017704) Immunofixation for Urine

175

2.01

3.68

2.1

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

567

1.55

3.68

1.8

1.9

4.19

5.06

mmol/24h

1.68

501

(3051651) Icteric interference index of Serum or Plasma

196

1.95

3.67

7.1

3.2

—

(3044007) Cell count panel - Peritoneal fluid

2.43

3.63

1.8

2.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

358

1.69

3.62

10.4

5.2

9.18

7.22

mmol/l

2.06

299

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

143

2.11

3.58

1.1

—

(3034426) Prothrombin time (PT)

111

2.26

3.54

1.3

1.2

—

(3004451) EKG impression Narrative

144

2.09

3.52

1.4

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

118

2.21

3.50

1.3

1.4

18.21

15.34

pmol/l

0.20

102

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.16

3.50

6.1

5.8

392.37

449.08

umol/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

448

1.59

3.47

1.1

1.53

1.50

g/l

0.34

407

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.62

3.46

1.8

1.3

—

(3000492) Spirometry study

403

3361

1.22

3.45

1.6

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

273

1.77

3.45

1.2

—

49.69

—

(3029075) Extractable nuclear Ab panel - Serum

2.35

3.40

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.10

3.36

1.8

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

199

1532

1.31

3.34

4.3

3.1

34.11

58.34

u/ml

1.97

192

1474

(3034274) Bile acid [Moles/volume] in Serum --fasting

437

1.59

3.33

2.2

2.4

5.72

7.67

umol/l

0.63

317

(3044009) aPTT.lupus sensitive (LA screen)

3.94

3.28

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

104

723

1.45

3.26

1.1

5.35

2.39

u/ml

0.95

372

(3020911) Cortisol [Moles/time] in 24 hour Urine

103

2.24

3.22

1.2

1.5

69.26

149.42

nmol/24h

0.70

103

(3030313) Adrenal Ab [Titer] in Serum

4.17

3.19

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

185

1.90

3.19

2.2

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

178

1.92

3.18

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

104

2.22

3.15

1.7

3.3

—

(3016018) Differential panel - Cerebral spinal fluid

350

1.64

3.14

3.1

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

180

1.90

3.09

1.4

1.3

151.56

133.22

nmol/l

1.19

180

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.33

3.07

1.4

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.38

3.05

2.1

1.4

11.48

13.55

g/l

0.49

(3041672) Baker's yeast Ab [Presence] in Serum

4.29

2.99

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

134

1791

0.74

2.98

1.6

1.7

—

(3017569) Oxygen content in Arterial blood

148

1.97

2.94

2.9

2.3

—

(3025577) Chromium [Mass/volume] in Blood

191

1.84

2.92

1.9

2.0

4.14

2.28

ug/l

0.58

164

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

135

2.01

2.90

2.4

2.3

126.91

158.93

nmol/l

1.05

118

(3043410) Blood group antigens tested for on Red Blood Cells

2.22

2.89

1.5

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

208

1646

1.28

2.88

1.1

—

150.03

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.71

2.87

6.2

4.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.43

2.87

1.2

2.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

102

2.16

2.86

2.5

2.2

9840.80

20703.15

e6/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

126

931

1.36

2.84

1.1

7.25

4.43

u/ml

0.22

125

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

186

1.83

2.82

2.2

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

708

0.60

2.82

2.1

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

440

1.53

2.82

1.3

1.2

0.32

0.31

nmol/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.34

2.81

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

662

1.43

2.80

1.1

6.16

5.10

u/ml

0.22

360

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.45

2.79

1.1

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

404

1.54

2.71

1.4

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

160

1.88

2.70

3.0

2.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.01

2.69

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.76

2.67

1.0

1.1

—

41.55

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

119

2.02

2.65

4.0

3.0

—

152.66

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

636

1.42

2.65

1.1

0.80

0.99

u/ml

0.19

280

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

384

1.54

2.61

1.4

1.3

—

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

221

1.73

2.60

1.2

1.1

—

(3019174) dRVVT (LA screen)

3.34

2.60

1.4

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.06

2.56

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.51

2.53

2.2

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.98

2.48

2.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1232

11425

1.11

2.48

4.7

4.8

2.17

3.55

ug/l

1.98

1106

10259

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

123

1615

0.75

2.48

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.38

2.47

77.3

5.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

612

1.41

2.46

1.1

1.43

1.98

u/ml

0.45

312

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

496

1.46

2.45

1.3

1.5

0.32

0.39

nmol/l

0.50

393

(40758292) HTLV I+II Ab panel - Serum

2.46

2.44

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

188

1.76

2.44

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.29

2.41

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.29

2.41

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

2.29

2.41

1.1

1.3

231.19

44.44

mu/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.12

2.38

4.5

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.12

2.38

4.5

2.5

—

(40768441) Liver Pathology biopsy report

235

1.67

2.38

1.9

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.61

2.35

2.1

1.8

137.25

123.96

ng/l

0.14

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

427

1.48

2.34

1.2

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.26

2.34

1.5

1.1

109.86

76.52

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.05

2.31

1.2

—

(40768793) Breast Pathology biopsy report

654

1.38

2.31

1.4

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

612

1.40

2.30

1.5

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

192

1.72

2.29

1.5

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

1.80

2.25

3.1

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

106

1.99

2.25

1.2

1.3

85.64

85.75

0.00

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

548

1.41

2.23

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

179

1.74

2.22

8.4

6.1

32.44

15458.78

u/ml

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

108

1.95

2.15

1.2

1.1

79.18

87.67

0.46

(3012494) Peanut IgE Ab [Units/volume] in Serum

108

1.95

2.15

1.1

0.46

2.62

u/ml

1.70

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

272

2296

1.20

2.14

1.2

79.97

143.36

iu/ml

3.82

104

849

(3035880) pH of Pleural fluid

174

1.73

2.13

1.5

1.3

—

(3010503) CD19 cells [#/volume] in Blood

205

1.66

2.10

1.9

2.8

1.18

0.24

e9/l

0.46

199

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.20

2.09

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.71

2.06

14.3

7.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

653

1.36

2.02

3.0

3.5

570.60

724.40

u/ml

0.12

602

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.40

2.02

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

223

1.62

2.02

1.1

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

231

1.61

2.01

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.64

2.00

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.82

2.00

2.3

2.2

—

(3017509) Phencyclidine [Presence] in Urine

2.82

2.00

4.9

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

224

1.61

1.99

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

344

1.49

1.99

4.3

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

241

1.58

1.95

2.0

1.80

1.72

u/field

0.04

100

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.25

1.90

9.1

7.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.25

1.90

1.2

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

406

1.43

1.89

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

1.82

1.88

1.3

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.86

1.86

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.09

1.86

1.3

1.2

93.67

70.26

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

350

1.46

1.85

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

144

1.74

1.84

1.2

1.3

151.02

160.32

mmol/24h

0.35

144

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

318

1.48

1.83

1.6

2.6

19.81

20.08

nmol/l

0.06

300

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.17

1.82

5.8

3.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.12

1.81

2.2

2.1

17.61

18.58

umol/l

0.10

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

191

1.63

1.80

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

1.5

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.09

1.75

1.4

1.2

25.50

26.41

g/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

214

1806

1.19

1.74

1.1

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.94

1.74

1.9

1.3

17.27

17.08

umol/l

0.04

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.74

3.1

2.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.23

1.73

1.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

249

1.53

1.73

1.4

1.3

1.02

2.24

u/ml

0.80

136

(3008898) HLA-B27 [Presence]

147

1197

1.24

1.72

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.85

1.71

1.6

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

562

1.34

1.67

1.1

—

11.79

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.16

1.66

5.2

4.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.16

1.66

5.2

4.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.58

1.66

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.80

1.65

8.9

4.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.80

1.65

1.1

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.44

1.64

6.7

3.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

3.0

6.6

—

(3025130) Human papilloma virus identified in Specimen

412

1.39

1.60

1.7

1.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.00

1.58

1.8

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

144

1.67

1.57

1.2

1.1

11.55

6.41

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

114

1.76

1.56

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

114

1.76

1.56

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

623

0.70

1.54

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

441

1.37

1.53

1.3

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.83

1.51

1.3

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

108

1.76

1.50

1.1

15.18

15.34

u/ml

0.01

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

384

1.39

1.49

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

124

1.70

1.47

1.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.50

1.45

7.9

8.0

—

(3051593) INR in Capillary blood by Coagulation assay

140

1.65

1.44

1.3

12.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.88

1.44

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

237

1.48

1.41

1.8

1.5

79.09

83.74

umol/l

0.34

237

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.18

1.39

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

238

1.47

1.39

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.77

1.38

1.3

2.1

—

(40761536) Microorganisms panel - Urine sediment

319

2835

1.14

1.38

6.2

3.8

—

(3006270) Folate [Moles/volume] in Blood

273

1.43

1.35

1.4

1.2

345.41

378.26

nmol/l

0.38

243

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.13

1.33

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

789

1.25

1.33

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.50

1.30

2.5

2.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.84

1.29

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

276

1.42

1.28

1.2

1.1

36.11

41.16

mg/l

0.67

225

(40768795) Lymph node Pathology biopsy report

310

1.39

1.28

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

235

1.45

1.26

1.4

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

219

1.46

1.25

1.0

1.1

0.79

2.93

u/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.40

1.24

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

789

0.77

1.24

1.5

—

(4034850) Laboratory test

127

1061

1.20

1.23

14.1

9.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

697

0.76

1.22

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.63

1.21

4.8

5.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

101

827

1.23

1.20

1.8

1.9

3.63

4.59

iu/l

0.50

295

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

918

0.79

1.19

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

694

0.76

1.19

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.88

1.18

2.3

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

715

0.77

1.18

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

463

1.30

1.17

1.1

9.39

4.42

u/ml

0.78

186

(3014599) Egg white IgE Ab [Units/volume] in Serum

216

1.44

1.13

1.0

1.1

0.49

1.15

u/ml

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.85

1.13

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

318

1.36

1.12

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

113

0.44

1.12

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.34

1.12

2.9

2.4

1.14

0.67

u/field

—

(4146454) Self-monitoring of blood glucose

327

1.35

1.12

2.9

2.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

208

0.58

1.11

1.4

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

142

1217

1.17

1.07

1.5

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

194

1.45

1.06

1.0

1.1

0.32

4.91

u/ml

—

(40762365) Oxygen content in Arterial blood by calculation

1.93

1.06

2.9

2.6

14.37

15.24

ml/dl

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

154

1.50

1.03

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.06

1.02

1.3

—

(40757373) Influenza virus identified in Isolate

1.69

0.95

2.2

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

708

0.80

0.90

1.5

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

306

1.31

0.88

2.9

3.0

161.64

51.18

mg/l

1.03

232

(3000285) Sodium [Moles/volume] in Blood

1.91

0.88

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

228

1.36

0.88

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

1.51

0.88

1.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.79

0.87

1.1

1.9

—

(3014891) Appearance of Pleural fluid

1.86

0.87

1.1

—

(3001729) Color of Synovial fluid

2.00

0.87

1.3

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

0.87

1.3

1.7

53.00

43.60

umol/l

—

(40768800) Prostate Pathology biopsy report

703

0.81

0.85

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

844

0.83

0.84

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.78

0.84

3.3

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

171

1.41

0.83

1.9

1.6

1.00

3.69

u/field

1.32

126

(3050129) First trimester maternal screen panel - Serum or Plasma

1047

0.85

0.82

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

155

1.42

0.81

5.3

4.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1075

0.85

0.79

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

259

1.32

0.79

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

510

1.22

0.78

1.0

1.1

9.31

3.68

u/ml

1.45

245

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

847

0.84

0.78

1.4

—

(1002224) Polysomnography panel

158

1405

1.13

0.78

1.1

—

(4281824) Cell count and differential, peritoneal fluid

313

1.28

0.77

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

846

0.84

0.77

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

845

0.84

0.77

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

521

1.21

0.76

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

197

0.66

0.75

1.2

1.1

0.98

1.12

u/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

161

0.62

0.75

1.1

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

0.74

2.3

3.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.64

0.73

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.67

0.72

1.1

3.1

2.10

2.15

mmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.75

0.71

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

291

1.27

0.70

1.5

1.4

162.86

201.89

pmol/l

0.50

291

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.92

0.70

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.56

0.68

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.56

0.68

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.56

0.68

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.56

0.68

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.67

0.68

1.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

213

1.32

0.68

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.57

0.65

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.50

0.63

1.4

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

879

0.86

0.62

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

434

1.20

0.61

1.0

1.1

0.26

0.28

u/ml

0.03

133

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

256

0.74

0.61

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.59

0.0

1.2

—

1.08

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.53

0.59

3.7

2.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.72

0.57

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.62

0.55

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

213

1.27

0.53

1.5

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

100

1.40

0.51

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

206

1.26

0.50

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

553

0.85

0.50

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

198

1.26

0.49

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.52

0.48

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

102

1.37

0.47

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

943

9157

1.04

0.47

4.4

4.1

22.50

21.68

0.82

432

4366

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.45

1.2

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

209

0.76

0.45

1.4

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

379

3612

1.05

0.44

1.5

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.61

0.43

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.38

0.41

2.4

1.9

39.88

27.65

pmol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.52

0.41

3.4

1.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.52

0.41

1.8

1.1

14.08

15.70

g/l

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.52

0.41

2.2

1.5

24.00

14.96

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.13

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.40

0.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.47

0.40

1.6

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.47

0.40

1.2

1.1

1.80

1.90

umol/24h

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.31

0.39

1.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

101

0.69

0.39

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.34

0.39

1.4

1.3

56.65

53.76

0.09

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.39

0.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

367

0.84

0.38

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

151

1.26

0.38

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.39

0.38

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.35

0.37

1.2

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.35

0.37

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

157

0.76

0.35

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

135

1.26

0.35

1.9

2.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

137

1276

1.08

0.35

2.0

1.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

510

1.12

0.33

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

231

0.82

0.32

1.4

1.5

8.01

7.81

mmol/l

0.11

223

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

446

1.12

0.31

1.3

7.54

7.18

mmol/l

0.33

398

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

219

0.82

0.31

1.1

1.3

1.49

1.56

g/l

0.34

219

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.32

0.30

1.0

1.2

—

(3016228) CD19 cells/100 cells in Blood

140

1.22

0.27

1.9

2.1

15.29

9.39

0.39

135

(3020650) Glucose [Presence] in Urine

1.26

0.26

1.2

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.30

0.26

1.1

0.01

8.51

u/ml

—

(3006462) Nitrate [Presence] in Urine

149

0.80

0.25

4.0

3.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

1.24

0.24

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

105

1.24

0.24

2.0

2.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.24

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

148

0.81

0.24

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

191

0.84

0.24

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

246

1.14

0.23

2.5

1.6

9.46

6.70

mmol/l

1.47

170

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.33

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.23

0.21

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.23

0.21

1.2

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.25

0.20

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.21

0.19

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.15

0.19

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

207

0.87

0.19

6.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.18

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

299

1.10

0.18

1.5

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

706

1.06

0.18

3.9

3.2

29.86

26.99

mg/l

0.22

431

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

119

1.18

0.17

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.13

0.16

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.20

0.16

1.6

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

381

3730

1.02

0.15

1.8

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.13

0.15

3.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

508

4998

1.02

0.14

1.6

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

491

1.06

0.13

1.1

3.04

2.71

u/ml

0.13

225

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

107

1031

1.04

0.12

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

127

0.87

0.12

1.4

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

1.15

0.12

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

303

0.92

0.12

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

655

6631

0.99

0.12

3.0

0.71

0.75

ug/l

0.71

440

4342

(3013293) Extractable nuclear Ab [Presence] in Serum

1.06

0.09

2.4

1.7

—

(44813793) Dust mix specific IgE antibody measurement

223

1.08

0.09

1.2

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

556

0.97

0.05

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

1.10

0.05

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

122

1.07

0.02

4.9

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

133

1.05

0.01

1.4

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

133

1.05

0.01

1.8

2.9

1.82

1.18

ug/l

—

123

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

317

0.98

0.01

4.1

5.0

164.84

79.11

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

556

0.99

0.00

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

218

1.01

0.00

1.0

255.19

322.38

ng/l

1.16

146

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

217

1.01

0.00

1.0

828.93

721.77

ng/l

0.63

141

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

101

0.99

0.00

4.4

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

101

0.99

0.00

2.2

3.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

219

1.00

0.00

1.0

35.72

45.94

ng/l

0.83

143

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

127

1267

1.00

0.00

1.8

1.7

4.47

3.85

mg/l

0.47

100

908

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.87

0.00

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.93

0.00

1.0

1.4

0.00

1.58

u/ml

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.02

-0.00

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.02

-0.00

1.2

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.02

-0.00

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

1.00

-0.00

1.0

6.53

8.32

mu/l

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.98

-0.00

1.2

1.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.85

-0.00

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.96

-0.00

1.7

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_INFECT_SKIN_NAS – Other and unspecified local infections of skin and subcutaneous tissue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other and unspecified local infections of skin and subcutaneous tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other and unspecified local infections of skin and subcutaneous tissue (L12_INFECT_SKIN_NAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints